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ABSTRACT
Toxoplasma gondii is the most successful zoonotic pathogen known today. One-third of people
are chronically infected worldwide. Different strains of T. gondii shows variability in mouse
virulence which may potentially correlate with disease manifestation in humans. As a result,
mouse is used as the model organism to study the virulence of T. gondii strains. To study the
virulence on a global scale, it is necessary to establish a standardized approach for mice
virulence assays. Thus, we review the methodologies used in different labs and put forth
standardized approaches to study the T. gondii virulence in mice (Chapter 1). Recent
advances in diversity and population structure of T. gondii had shown that even though the
dominant type II strain is spread globally, it is particularly dominant in the region of Europe.
Thus, to understand the origin and transmission pattern of the type II dominant lineage of T.
gondii (Chapter 2), we tested the hypothesis that the current distribution structure and
dominance of type II T. gondii in Europe is because the most recent common ance stor
(MRCA) of type II originates in the continent of Europe. Based on our study we found that
type II dominant lineage originated in the Old World and has transmitted to the New World
(America). To further examine the migration pattern of second most dominant type III T. gondii,
diversity among isolates was analyzed.

Based on previous knowledge, in Chapter 3 we tested

the hypothesis that, despite the diversity of genotypes in South America, the higher
frequency of type III lineage is because the most recent common ancestor (MRCA) of type
III originated on this continent. Our study revealed that origin of type III lineage is in the New
World close to Central America and that the dissemination pattern is from New World to the Old
World. In Chapter 4 we studied the seroprevalence rates for 471 and genotyped (n=19) wild life
samples of T. gondii in the southeastern United States. We found high seroprevalence rates
amongst game meat animals (white-tailed deer and feral hogs) which could be a potential
risk for humans consuming contaminated meat.
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1. Overview
Toxoplasma gondii is one of the most successful pathogens on earth, capable of infecting a broad
range of mammals and birds [1]. It belongs to the phylum apicomplexan which also includes
other medically significant members such as Plasmodium, Cryptosporidium, and Babesia. Felids
are the only known definitive hosts in which sexual replication of the parasite occurs, resulting in
the dissemination of oocysts into the environment via defecation, thus felids play a critical role in
the transmission of T. gondii. Mammals and birds are intermediate hosts in which asexual
replication of T. gondii occurs, which generates a large number of fast-replicating tachyzoites
during acute phase infection. This phase is followed by a growth switch to slow-growing
bradyzoites in tissue cysts. It is estimated that one-third of the world’s human population is
chronically infected with this parasite [1]. Humans become infected by ingesting oocysts from
contaminated food and water, consuming undercooked meat containing the tissue cysts, or
vertical transmission of tachyzoites from mother to fetus [1, 2]. Primary infection in
immunocompetent individuals is mostly asymptomatic but in some cases can lead to ocular
toxoplasmosis [3]. In immunocompromised individuals, such as AIDS patients, reactivation of
chronic infection can cause life-threatening encephalitis [1, 4].

2. Life Cycle
Toxoplasma gondii has three distinct forms: 1) sexually-reproduced sporozoites, 2) the fastreplicating tachyzoites, and 3) slow-replicating bradyzoites. Sexual replication of T. gondii is
restricted to felids. Felids can ingest oocysts from environmental sources or tissue cysts from
chronically infected prey [1, 2] (Figure 1.1). The cyst wall is ruptured due to acid pepsins
present in the felids stomach. Once released, the sporozoites or bradyzoites invade the epithelial
cells of the intestine and differentiate into schizonts. The parasite then forms merozoites which
later differentiate into male and female gametes. The gametes fuse together to form diploid
oocysts and are shed in the feces of the felines. The time between the infection and shedding of
oocysts is generally 3-10 days [1, 5]. A single cat can shed up to 20 million oocysts per day in its
feces [6]. When released in the environment, these oocysts can sporulate under ambient
temperatures producing eight haploid sporozoites enclosed in the wall of the cyst. The oocysts
can survive in moist soil and water for up to 18 months which prolongs their survival in the harsh
environments [7].
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Almost all warm-blooded animals and birds can serve as an intermediate hosts for T.
gondii. Intermediate hosts are infected via sporozoites in oocysts from contaminated water
sources as well as via tissue cysts in contaminated meat sources (Figure 1.1). On ingestion of
oocysts, the sporozoites are detectable in the small intestine within hours of infection [8]. The
sporozoites then differentiate into tachyzoites and replicate rapidly [1]. Upon consumption of
contaminated meat containing tissue cysts, the cyst wall is dissolved due to acid-pepsin in the
host’s stomach and bradyzoites are released. In mice, bradyzoites differentiate into tachyzoites
within one hour and enter into a rapidly- replicating form by two hours post infection. Fast
replicating tachyzoites enter the lymph nodes by 48 hours and can disseminate by infecting
migratory cells like dendritic cells and macrophages[1]. Eventually, the tachyzoite form is
converted to a more slowly-replicating, dormant form of bradyzoites. Bradyzoites enclosed in the
cyst wall are resistant to immune responses and are retained primarily in brain and muscle for the
lifespan of the infected host [8, 9].

3. Virulence
Susceptibility differences to T. gondii infection have been reported among closely related species
[1]. For examples, rats (genus Rattus) are generally resistant (form chronic infection) to
toxoplasmosis, whereas house mice (Mus musculus) are highly susceptible compared to most
other hosts[1]. Mice are generally selected as the model organism for testing the virulence of
Toxoplasma. As house mice are more susceptible to T. gondii, a difference in the susceptibility is
observed among different strains of the parasite. Toxoplasma strains can, therefore, be classified
into virulent and avirulent categories. Parasite strains causing 100% mortality in mice at a dosage
of as low as one parasite are considered to be virulent. Some strains, on the other hand, require a
high dosage to achieve mortality, and subsequent infection with low dosage leads to chronic
infection in mice [10, 11]. In the early 1990’s using PCR-RFLP (Polymerized chain reactionRestriction fragment length polymorphism) based genotyping of strains it was observed that all
the virulent strains fall in the
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Figure 1.1: Life cycle of T. gondii [222].
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category of type I lineage and non-virulent strains belonged to either the type II or III lineages of
the parasite [10, 12]. Later, PCR-RFLP based genotyping study on T. gondii samples from
Europe and North America suggested that the population structure of Toxoplasma was
dominated by the three clonal lineages type I, II and III [11]. This observation led to the
investigation of the genetic differences among the lineages and how they lead to differences in
mouse virulence.

4. Genetic Basis for Differences in Virulence
The first evidence for virulence differences emerged from mapping the progeny from sexually
crossed type I, II and III clonal lineages using Quantitative Trait locus (QTL) analysis [13] [14].
From these studies, two major virulence genes rhoptry protein 18 (ROP18) and ROP5 were
identified in T. gondii [13-15]. The first key virulence factor identified was the ROP18 kinase
[14]. The main function of ROP18 is to interact with immunity-related GTPases (IRGs) and p65
guanylate binding proteins (GBPs) that are known to localize to the parasitophorous vacuole
membrane (PVM), ultimately causing disruption of the PVM and leaving the parasites
vulnerable to clearance by other host defense mechanisms [16-19]. Thus, functional ROP18 is
required by T. gondii for evasion of the host immune system. In the crosses generated, it was
revealed that types I and II express a functional ROP18 allele and are thus included in the
virulent category. In contrast, the ROP18 allele of type III clonal lineage has an insertion in the
promoter region that attenuates expression of the gene, making it non-functional [20]. ROP5 is a
rhoptry-secreted pseudo kinase, non-functional kinase by itself due to a mutation in the catalytic
site and is correlated even more strongly with virulence than ROP18 [21]. ROP5 plays a role in
the suppression of the immune system via formation of a complex with ROP18 and murine IRGs
[21, 22]. Functional ROP5 alleles are expressed by clonal types I and III. In the case of type I
strains, the expression of both functional ROP5 and ROP18 alleles appears to account for the
hyper virulence of this lineage. On the other hand, the ROP5 allele of type II is nonfunctional, so
that this strain type is avirulent despite expression of functional ROP18 [15, 22]. ROP17 is
another rhoptry protein that was found to interact with ROP5. The combination of ROP17 and
ROP5 also determines virulence similar to RO18 and ROP5 interaction but the interaction is less
significant in comparison to the combination of ROP5 and ROP18 [21]. Recently, using PCR –
RFLP technique, genotyping was performed for four loci ROP5, ROP18, ROP 16 and ROP17 for
5

240 strains collected globally [23]. Comparing the genotyping data with the previously published
mouse virulence data for these strains, it was shown that there is indeed an association between
the genotypes of the ROP5 and ROP18 allele and virulence in mice. ‘

5. Human Toxoplasmosis
One-third of the human population is infected with T. gondii [24]. For immunocompetent
individuals, the general symptoms of the acute infection include fatigue, fever, muscle and joint
pain [1]. Approximately two weeks after acute infection, the parasites enter into the chronic
phase and maintain infection for the entire life of infected host [25, 26]. In the United States, the
seroprevalence rate ranges between 10-38%. In other regions like China, UK and Korea the
seroprevalence percentage is lower and estimated to be 11, 8 and 4% respectively [1, 3]. These
geographical differences in the infection rate are the reflection of the dietary habits in that
particular

region.

However,

severe

cases

of toxoplasmosis

are

typically reported

in

immunocompromised people like AIDS, cancer or organ transplant patients. The majority of
AIDS patients infected with Toxoplasma suffer from formation of necrotic lesions in the brain,
which are associated with encephalitis as well as pneumonia and other systemic forms of the
disease. These severe cases of toxoplasmosis are a result of reactivation of latent infection when
the immune system is compromised or suppressed [1]. However, recent studies have also
reported severe cases of toxoplasmosis in immunocompetent people [3, 27-29].
5.1 Ocular Toxoplasmosis

Ocular toxoplasmosis (OT) is one of the most common infections observed in nearly 18% of
adults in Southern Brazil compared to 2% of adults in Europe and the United States [3]. The
infection can result in scarring of the ocular tissue leading to vision impairment. A large number
of ocular toxoplasmosis cases in South America manifest more severe clinical symptoms. For
example, eye lesion and impaired vision cases are more common in children and the lesions
formed are much larger in size and multi focal when compared to cases from Europe. This
relatively high number and increased severity in South America is hypothesized to be linked to
the atypical strains of T. gondii dominant in regions like Brazil. Similarly, another study in 2011
reported that 18 out of 20 tissue samples collected from toxoplasmosis patients in Sao Paulo,
Brazil belonged to genotype # 65 which comprises a small fraction of total T. gondii strains
6

found in this region [30]. Additionally, the majority of Colombian OT patients were found to be
infected with atypical or type I virulent strains of T. gondii [30]. All this evidence indicates that
the strains circulating in the environment determine the disease manifestation in humans residing
in that region.

5.2 Congenital Toxoplasmosis
Toxoplasma can also be vertically transmitted from mother to fetus and, as a result, is a major
health concern for pregnant women. The higher seroprevalence rates reported in pregnant
women also highlights this threat. Seroprevalence rates as high as 61% and 84% were
documented in France and Madagascar respectively. In regions like Brazil where undercooked
meat is consumed daily, the seroprevalence can range between 61-92% [3, 31]. In general,
pregnant women infected for the first time during pregnancy can vertically transmit the parasite
to the developing fetus during the acute infection stage. Even so, few cases of vertical
transmission have been reported due to chronic infection or preexisting infection before
pregnancy [32]. Thus, women infected during pregnancy are likely at a greater risk for
abnormalities in the fetus. The severity of the symptoms due to the vertical transmission varies
depending on the gestational stage of the pregnancy.

More severe outcomes of infection are

reported during the first trimester of pregnancy, while infections occurring during the later stages
of pregnancy have less severe symptoms, but are more prone to congenital infection. The
manifestation of the infection during pregnancy can include ocular disease, congenital defects
and pregnancy loss [1].

5.3 Severe Disseminated Toxoplasmosis
Severe cases of toxoplasmosis have also been reported in the population of French Guiana [28].
Of the 44 cases of severe primary toxoplasmosis reported from the period of 1998-2004, onethird were hospitalized for respiratory distress. Genotyping studies revealed that the majority of
strains infecting these patients belonged to the atypical category. In addition, 11 cases of multivisceral toxoplasmosis were reported from Patam village in French Guiana from December 2003
to January 2004. Eight out of 11 patients were found to be immunocompetent and genotyping
studies revealed one atypical genotype infecting all the patients [28]. Organ failure was also
reported in 11 immunocompetent adults of French Guiana, thus requiring intensive care. This
7

severe form of systemic toxoplasmosis called ‘Amazonian toxoplasmosis’ and is speculated to be
a result of spillage of strains circulating among wild animals to intermediate hosts like humans
and domestic animals in that region [28, 33]. Wild definitive hosts are generally more resistant to
T. gondii which leads to the selection of more virulent strains causing more severe infection in
the intermediate hosts in close proximity. In other regions like Europe, where type II strains are
found to be most dominant, the majority of OT cases were found to be caused by the virulent
type I or atypical strains of T. gondii [34, 35].

6. Population Structure
Early genotyping studies of 106 isolates from Europe and North America using 6 PCR-RFLP
markers divided T. gondii isolates into three clonal types denoted as types I, II and III [11]. It
was suggested that the global population structure of T. gondii was largely clonal with three
archetypical lineages (type I, II and III) dominating the entire world. However, recent advances
have revealed that the population structure of T. gondii is more complex than previously thought
[36, 223]. The most recent data on diversity structure of Toxoplasma have been obtained from a
study performed on 1457 isolates using 10 PCR-RFLP markers (Figure 1.2) [36]. A total of 189
ToxoDB PCR-RFLP genotypes were found from these isolates of T. gondii collected worldwide.
The population structure in the northern hemisphere appears to be largely clonal, whereas the
southern hemisphere samples show a diverse population structure. In Europe, the majority of the
isolates studied belonged to ToxoDB genotypes #1 and #3 that together are recognized as type II
lineage [223]. The second dominant lineage in Europe was found to be #2 that is known as type
III lineage. However, genotype #10 (type I) [223] constituted a relatively lower percentage of the
total population. This shows that the European population structure is mostly clonal which is in
agreement with previous report [11]. In North America, the majority of the population is
comprised of genotype #1 or #3 (type II) [223] strains, whereas genotype #2 (type III) strains
were also found in relatively higher frequency. Interestingly, genotypes # 4 and # 5, together
known as type 12 [223] were found in high frequency in wildlife. In Eastern Asia, genotype #9
(Chinese type I) was found to be widespread followed by #10 [223]. Other genotypes identified
in this region were genotypes #4, #18 and #20 [223]. Overall, the population structure in Asia
was recognized to be clonal. In Africa, #2 and #3 accounted for the majority of the isolates.
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Figure 1.2: Population structure and diversity of T. gondii on a global scale [36].
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Additionally, genotype #6 was observed [223]. Unlike other regions, the population structure in
Central and South America is highly diverse and there is a lack of predominant lineages.
Commonly found genotypes included in decreasing order, #2, #6, #7, #8, #11, #3, #65, #13, #19
and #146. However, in the geographical region which includes Chile, the three lineages
including ToxoDB genotype #1, #2 and #3 were found to be predominant (Figure 1.2) [36].
Overall, the current population structure for Toxoplasma appears to be much more complex with
the northern hemisphere showing a clonal structure, compared to the southern hemisphere which
is more diverse.

7. Immune Responses
7.1 Interferon Gamma
Interferon gamma (IFNγ) is one of the most important Th1 cell-mediated cytokines critical for
the control of T. gondii infection. Mice lacking the IFNγ gene have been shown to succumb to T.
gondii infection. The major cells producing IFNγ include neutrophils, T cells and NK cells [3739]. The main function of IFNγ is the expression of immunity related GTPases (IRGs) and
guanylate binding proteins (GBPs) [40-42]. The role of IRGs and GBPs is to disrupt the integrity
of the PV membrane leading to the release of the parasites in the host cytoplasm [43]. IRG
proteins can be divided into two groups (GKS and GMS) depending on their specific role.
Effector proteins (GKS) bind to the parasite membrane and are responsible for mechanically
disrupting the membrane. On the other hand, regulatory proteins (GMS) are required for
protection of the host intracellular membrane to prevent disruption via GKS proteins [18, 44].
The role of GBPs in parasite clearance is rather indirect and requires the recruitment of other
IRG proteins [42]. In addition to the expression of IRGs and GBPs, IFNγ also aids in limiting the
replication of the parasite by inhibiting tryptophan production. Interferon gamma induces the
production of indoleamine 2, 3- dioxygenase that converts tryptophan into an unusable form. As
T. gondii is a tryptophan auxotroph, the absence of tryptophan limits the parasite growth [45,
46].

IFNγ can also play a role in parasite inhibition via production of reactive oxygen and

nitrogen species (ROS and RNS) that have antimicrobial properties. It does so by inducing the
NO synthase gene using L-arginine as the substrate [47, 48].
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7.2 Tumor Necrosis Factor Alpha
Tumor necrosis factor Alpha (TNFα) alone cannot trigger parasite clearance and requires the
help of IFNγ [49]. Activated macrophages when primed with IFNγ and TNFα show enhanced
antimicrobial activity [50]. TNFα in conjunction with IFNγ can lead to parasite control by fusion
of PV to the lysosomes causing their degradation [51]. In macrophages, TNFα also plays a role
in the production of RNS having antimicrobial activity [52, 53]. TNFα can also act as a costimulatory molecule in NK cells. It has been shown that NK cells exposed to parasite antigen
along with TNFα produce IFNγ [37].

7.3 Interleukin -12 (IL-12)
Th1 cell-mediated response is known to be critical for parasite clearance; this is in part mediated
by upregulation of IL-12 which is required for the production of IFNγ [39, 54]. Mice infected
with lethal doses of the parasite shows enhanced survival on treatment with exogenous IL-12
[55]. The major circulatory cells involved in the IL-12 production are dendritic cells, monocytes
and neutrophils [56, 57]. In response to the secretion of chemokines like macrophage
inflammatory proteins 1 and 2 on infection with T. gondii, macrophages and neutrophils are
recruited to the lumen of the small intestine in mice [58-60]. This leads to the clearance of
parasites via processes like phagocytosis, antigen presentation and involvement of other immune
cells [57, 61-65]. The production of IL-12 is dependent on myeloid differentiation factor 88,
which is recruited to TLRs on the binding of pathogen-specific molecules [66].

7.4 Adaptive Immune Response
T and B cell mediated response is critical for the survival of humans as well as mice, especially
during the chronic infection stage. CD4+T cells are involved in the production of IFNγ as well as
mediation of B and CD8+T cell responses. CD8+ T cells, in turn, offer protection via production
of IFNγ and CD40L as well as perforin-mediated lysis of infected cells [67, 68]. CD4+T cells are
activated by dendritic cells (DCs) which are one of the most important antigen presenting cells
(APCs), in addition to other cells like B cells and macrophages [69]. B cell activation, in turn,
produces antibodies that provide protection via activation of complement pathway and
opsonization of the pathogen. CD8+ T cells are activated by T. gondii antigens like surface
antigen 1 (SAG1), dense granule proteins (GRA4 and GRA6) and rhoptry protein ROP7 [70].
11

8. Interconversion and Disease Pathogenesis
The life cycle of Toxoplasma consists of three stages sporozoites, tachyzoites, and bradyzoites.
Infections in immunocompetent individuals are mostly asymptomatic [1]. However, the key to
disease pathogenesis of this parasite is in part linked to its ability to convert into a dormant,
slowly replicating bradyzoite enclosed within a tissue cyst. Tissue cysts can hide from the
immune system and remain in the host indefinitely [71]. However, in immunocompromised
people such as AIDS patients or chemotherapy patients, tissue cysts can rupture and release
bradyzoites. Transformation of bradyzoites into tachyzoites can lead to parasite reactivation and
in some cases severe disseminated toxoplasmosis and life-threatening encephalitis. Therefore,
understanding the mechanisms behind the ability of tachyzoites to convert to bradyzoites is of
utmost importance.

The combination of drugs like sulfonamide and pyrimethamine are

commonly used to control the active infection. Sulfonamide is known to interfere with the folic
acid biosynthesis pathway by preventing the addition of para-amino benzoic acid (PABA).
Pyrimethamine, on the other hand, is a dihydrofolate reductase that blocks the biosynthesis of
purine and pyrimidines. Although drugs which control the tachyzoites in the active stage of
infection currently exist, no successful drugs have been developed to control the chronic
infection bradyzoite form [1, 72]. Hence, knowledge of the molecular prerequisites for
interconversion can be used to force the parasite into tachyzoites stage and then be targeted by
using known drugs.

8.1 Bradyzoites
Toxoplasma in the form of cysts can be maintained indefinitely in almost all the intermediate
hosts thereby sustaining its infectivity [8]. Within 2 hours of ingestion of oocysts, sporozoites are
detectable in the epithelial cells of the small intestine [1]. By 12 hours post infection, sporozoites
differentiate into tachyzoites and enter into a rapidly replicating stage by 48 hours [1, 73]. The
other route of infection in intermediate hosts is the ingestion of cysts in the contaminated meat.
Once tissue cysts are ingested by intermediate hosts, the cyst wall is digested by acids present in
the stomach. In mice, tachyzoites are detectable in epithelial cells 2 hours after infection. When
migratory cells like dendritic and macrophages are infected, tachyzoites spread in the host [74].
Eventually, factors like immune pressure or spontaneous conversion lead to conversion of
tachyzoites to the dormant bradyzoite form enclosed within the cyst wall [8]. Tissue cysts are
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formed within 6 to 7 days post infection. Cysts can be harbored for decades primarily in the
brain, skeletal muscle, and cardiac tissues. The reason why cysts are predominantly found in
these cells is not well understood. Bradyzoites are generally believed to be dormant however,
they can rupture periodically during the life time of an individual for reasons not yet known,
leading to reactivation of the disease [1].

8.2 Bradyzoites and Human Health
It was 50 years after the discovery of Toxoplasma when it was recognized that the parasite can
disseminate via contaminated meat sources [75]. This highlighted the fact that consumption of
undercooked meat may prove as one of the major routes of infection in humans and other
intermediate hosts. Upon ingestion of the tissue cysts via contaminated meat, bradyzoites are
released in the intestinal epithelial cells of the intermediate host and the asexual life cycle begins.
Later in the life cycle, the parasites enter into a slowly replicating dormant stage of bradyzoites
enclosed in tissue cysts[1]. Once an infection is established the parasite can maintain its
infectivity as tissue cysts, for the entire life span of the host. Even though bradyzoites are
believed to be dormant, in the conditions of immune suppressed conditions, e.g. cancer and
AIDS, the parasite can emerge from latency and convert back to the tachyzoites form and
reinvade other nucleated cells [76]. Thus, in 1980 when AIDS emerged, Toxoplasma became a
major threat [77]. Since bradyzoites can reside in different organs in humans, it is an additional
cause of concern during organ transplant procedures. These findings led to the beginning of
intense research for the understanding of important regulatory factors for switch between the
acute and chronic infection stages.

8.3 Surface Proteins and Heat Shock Proteins
Stage conversion from tachyzoite to bradyzoite is associated with changes in the stage-specific
surface antigens (SAG) [78]. The SAG superfamily of antigens can be divided into SAG1 and
SAG2 family of surface antigens [79]. The SAG1 family of proteins plays a role in surface
attachment of the parasite before the invasion. The SAG1 family comprises of SAG3, bradyzoite
specific recombinant BSR4, SAG related sequences (SRS) 1-4 proteins, SAG 5, SAG5.1 and
SAG5.2 [79]. SRS1-3 is specific to the tachyzoite stage, BSR4 is specific to bradyzoites and
SAG3 is found in both stages. Similarly, the SAG2 family consists of SAG2A and SAG2B-D.
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SAG2A and SAG2B are antigens specific to tachyzoite stage. On the other hand, SAG2C and D
are specifically expressed in the bradyzoite stage [80]. These differentially expressed surface
proteins can be used as a marker for the identification of parasite stages in in vitro assays.
Heat shock proteins (HSPs) are another family of stress-related proteins required for bradyzoite
development. Experiments using the drug Quercetin which specifically inhibit HSPs have shown
the suppression of the stage conversion process. Bradyzoite specific-antigen (BAG1), previously
known as HSP30, is a bradyzoite stage specific HSP commonly used to identify the cyst form in
cell culture experiments [81]. Studies have shown that deletion of the BAG1 gene reduces the
number of cysts in in vitro assays [82].

8.4 Triggers and Determinants of Bradyzoite Formation
In vivo determinants of tachyzoites to bradyzoite conversion
Various in vivo factors such as parasite cell cycle, stage specific metabolites, host cell type,
manipulation

of host

immune

responses,

translation and

transcription regulation,

cyclic

nucleotides, etc. are known to play a role in the differentiation process of T. gondii. These factors
are discussed below in more detail.
Bradyzoite development and maintenance is dependent on transcription of the required
genes which in turn is tightly regulated with the cell cycle stage of the parasite. Abrupt cessation
of the cell cycle does not lead to bradyzoite development of the parasite, which suggests that the
parasite requires the completion of the cycle in order to enter the G0 phase for completion of
differentiation process [83]. Mature bradyzoites isolated from the brains of mice infected with
oocysts were found to be stalled in the G0 phase of the cell cycle containing 1N DNA. On the
other hand, differentiating parasite population contained 1.8 to 2 N DNA and was discovered to
be in the S/G2 phase of the cell cycle [84, 85]. This shows that commitment to bradyzoite
formation requires an entry into the pre-mitotic phase.
The metabolism profile of the parasite is linked to the stage of life cycle. Metabolomics
studies have identified stage-specific isoforms of enolases (ENO 1 and 2) and lactate
dehydrogenases (LDH 1 and 2) [86, 87]. The LDH2 form of the enzyme LDH is found to be
specific to the bradyzoite stage and is resistant to acidic pH, making it functional during the
catabolism of amylopectin in bradyzoites [87]. This is in accordance with electron microscopy
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studies that show an increase in the number of amylopectins during the bradyzoite stage [88].
The enzyme enolase also shows stage dependent differences in the specificity and stability in the
interconversion phenomenon. This enzyme catalyzes the conversion of 2-phosphoglycerate (2PG) to phosphoenolpyruvate (PEP) in glycolysis [86]. The specificity of the bradyzoite stagespecific ENO1 form is three-fold greater than ENO2, even though both the isoforms have the
same Michalis constant (km). This indicates that stage-specific glycolytic flux can be regulated
via expression of different isoforms of enzymes [86].
The role of host cell type in differentiation is still unclear. Given that cysts predominate in
brain and muscle cells and that the yield of tachyzoites varies between different host cell types,
identifies the need of the elucidation of this process. The host cell type differences could be
attributed to several factors. It is possible that as neuron cells in the brain and muscles are longlived, the chances of finding cysts in these cells for a longer period of time is increased [9]. In
addition, the slowing of parasites replication, directed by host cell microenvironment, could also
promote

the

differentiation.

Studies

using

Compound

1(4-[2(4-flurophenyl)-5-(1-methyl

piperidine-4-yl)-1 H pyrrol-3-yl] pyridine), support this hypothesis [89, 90]. It was observed that
only Hela cells treated with compound 1 increase the expression of the human cell division auto
antigen 1(CDA1), which slows the parasite replication, thereby increasing the number of cysts
[91]. Parasites also exhibit spontaneous differentiation in certain cell types such as rat-isolated
CNS cells including microglia, neurons, and astrocytes, primary and continuous muscle cells for
type III VEG strain of T. gondii [92, 93]. This further supports the possible role of the host cells
in the differentiation process.
T. gondii has been shown to develop multiple strategies to evade the host immune
responses, as well as manipulate the cytokines required by hosts for its own benefit. It is known
that IFNγ dependent cell- mediated immunity is critical for killing the parasites during the acute
infection phase [41, 42]. Additionally, prolonged IFNγ treatment is required to kill the rapidly
dividing reactivated tachyzoites. However, in vivo experiments using mice infected in the
presence of IFNγ have shown that IFNγ promotes differentiation into bradyzoites [94]. It is
speculated that this effect is due to the induction of the nitric oxide synthase gene to form nitric
oxide [95, 96]. Treatment of cells with NO donor (sodium nitroprusside) causes an increase in
the number of cysts formed in vitro [81, 82, 92]. IL-12 is another key cytokine required for
protection of the host. Mice lacking IL12 succumb to the parasite infection due to uncontrolled
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replication [39, 55]. IL-12 is produced on the translocation of NF-kB from the cytoplasm to the
nucleus when pathogen -specific molecules bind to toll-like receptors (TLRs) and MyD88 is
recruited to the TLRs. Type I and III strains of Toxoplasma have been shown to block the NF-kB
translocation, thereby hindering IL-12 production [97-99]. In contrast, type II strains of T. gondii
promote the expression and translocation of NF-kB via secretion of GRA15, thereby increasing
the proinflammatory response [100]. Type II strains adapted to the proinflammatory response
increase in the host to maintain chronic infections for a longer period of time. Toxoplasma also
avoids killing by suppressing the production of NO, especially in macrophages. NO is produced
by nitric oxide synthase using arginine as the substrate. Toxoplasma secretes rhoptry protein
ROP16 that activates the STAT6 pathway in the host leading to the expression of arginase 1.
Arginase 1 is known to degrade arginine, thereby reducing NO production [47, 101]. As NO has
an

antimicrobial property,

limited

NO

availability

proves

beneficial for

the

parasite.

Furthermore, Toxoplasma being an arginine auxotroph requires exogenous arginine, and so,
limited NO availability decreases the rate of parasite replication, which then helps in the
differentiation process [101]. NO production is also blocked by a patatin like phospholipase
(TgPL1) [102, 103]. Lower levels of cytokines were found at 8 weeks post infection in mice
vulnerable to toxoplasmic encephalitis (TE) [104]. On the other hand, mice infected with a
mutated strain lacking the TgPL1 gene maintained high cytokine levels, protecting them from TE
symptoms. Thus TgPL1 is required for suppression of NO, leading to lower cytokine levels, and
formation of cysts in the brain [104].
Translation regulation can also play a role in regulating the differentiation process.
Eukaryotic initiation factor-2 (eIF2) is one of the most characterized factors known to play a role
under different stress conditions [105]. Similarly, in T. gondii, protein translation is blocked
when the alpha subunit of TgIF2α is phosphorylated by protein kinases TgIF2K-A to D [106,
107]. This reduced protein translation helps Toxoplasma to stall the parasite at the tachyzoite
stage in order to promote the induction of bradyzoite stage genes.
Transcriptome analysis of T. gondii at different stages of the life cycle revealed that stage
differentiation in T. gondii is a transcriptionally governed process. Recent studies have identified
a role of the plant AP2-like domain containing T. gondii protein (TgAP2XI-4) in acting as a
transcriptional regulator to control the expression of bradyzoite stage-specific genes [108]. This
AP2 domain containing protein localizes in the nucleus, and binds to the ‘CACACAC’ sequence
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specific DNA motif, and its expression peaks after cytokinesis [109]. Transcript levels of this
protein were higher in cysts isolated from the brain than in rapidly dividing tachyzoites. Thus,
transcription regulation of stage-specific genes can govern the parasite differentiation.
The role of cyclic nucleotide pathways in differentiation was studied in two T. gondii strains
ME49 and PLK. The numbers of bradyzoites were increased in vitro when HFF cells, infected
with T. gondii strains, were treated with cGMP and cAMP nucleotides [110, 111]. Additionally,
infection conducted using forskolin, an agent used to transiently increase cAMP levels, induced
tachyzoite differentiation [110]. Further investigations revealed the involvement of the protein
kinase catalytic subunit TgPKAc3 in the bidirectional regulation of differentiation [110]. This
suggests that cyclic nucleotide signaling pathways are involved in stress- induced differentiation
and are dependent on protein kinase subunit -3 [110].
Bradyzoite pseudo kinase 1 (BPK1) expressed during early stages of cyst formation, was
found to be influential in the infectivity and development of cysts [112, 113]. Using
immunoprecipitation techniques, BPK1 was found to interact with four associated proteins;
MAG1, MCP4, GRA8 and 9. Deletion of the BPK1 gene resulted in the formation of cysts that
were smaller in size with lower oral infectivity [113].
Some strains of T. gondii show spontaneous stage conversion in vitro. Sporozoites or
bradyzoites of the VEG strain (ToxoDB genotype #2, type III) were inoculated in HFF cells and
were found to readily convert into tachyzoites stage. After approximately 20 divisions, the
sporozoites slowed their growth uniformly leading to bradyzoite formation [84, 85]. Specific T.
gondii strains are therefore able to follow a defined course of development without the need for
any external factors.

Serial analysis of gene expression profile (SAGE) also revealed that a 15-

day sporozoites culture contained a mixed population of tachyzoite and bradyzoite stage
parasites, with a gene expression profile similar to pH stressed parasites [85]. Together, these
data suggest that parasites are programmed to slow their replication in order to enter into the
bradyzoite stage.

In vitro Stresses Inducing Bradyzoite Formation
Exogenous stress can trigger differentiation, leading to cysts formation in vitro. Immunological
factors are therefore not necessary to trigger bradyzoite development. Discussed below are the
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commonly used external stress inducers and stress related changes in the parasite which lead to
the conversion of tachyzoite to bradyzoite.
Growing Toxoplasma under alkaline conditions is one of the most commonly used
strategies for bradyzoite development [114-116]. Experiments using human fibroblast cells
(HFF) infected with the ME49 strain of T. gondii were shown to readily form cysts (3-4 days) by
using an alkaline pH medium [116]. Changing the pH of the medium after infection or
preconditioning of the HFF cells in alkaline pH for an hour before invasion leads to bradyzoite
formation [114]. Use of alkaline pH conditions, however, is not considered to be a
physiologically relevant stress factor [114]. This is of concern when trying to identify the
molecular mechanisms behind the conversion process.
Tachyzoites can be converted to bradyzoites in vitro using heat stress. Studies have
identified a role of heat shock family proteins (HSPs) in the conversion of tachyzoites following
heat stress [81, 114]. HSP30/Bag1, HSP72, and HSP90 are a few HSP family proteins that have
been identified to play a role in cysts production [81, 117, 118]. When parasites are allowed to
invade preconditioned thermotolerant human fibroblast cells (HFF) cells at 37°C and then are
heat shocked for 2 hours at 43°C, they readily form cysts in vitro [119, 120]. It currently remains
unknown whether fever/high- temperature conditions symptoms during acute toxoplasmosis in
humans induces the bradyzoite formation.
Of all the methods currently used to study conversion of tachyzoites to bradyzoites, use of
NO is most physiologically relevant [81, 95, 110]. In vivo, NO is produced in response to the
production of IFNγ and acts on the iron-sulfur center of proteins involved in the parasite
respiratory chain [95, 121]. Sodium nitroprusside (SNP) is the most commonly used NO donor
drug in in vitro experiments and triggers bradyzoite differentiation in almost all host cell lines
[81, 92, 95].
Tachyzoites replicate faster than bradyzoites and as a result, require a higher concentration
of nutrients. Recent studies have shown that deprivation of the amino acid arginine induces the
formation of bradyzoites [122]. Toxoplasma, an arginine auxotroph, relies on the host arginine
supply [122]. Thus, in the absence of external arginine, replication of the parasite is blocked,
leading to the formation of bradyzoites. Additionally, inhibition of pyrimidine de novo
biosynthesis and the salvage pathway has also shown to induce conversion of tachyzoites. T.
gondii has a truncated pyrimidine salvage pathway and thus requires uracil phosphoribosyl
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transferase gene (UPRT), as well as CO 2, for the de novo synthesis of pyrimidines [123].
Altogether, deprivation of specific nutrients can be used as a strategy to study the molecular
perquisites for the differentiation of the parasite.

9. The Goal of Current Research
Susceptibility to T. gondii infection varies between intermediate hosts. House mouse (Mus
musculus) being more sensitive, variability in mouse virulence exists for different strains of T.
gondii [1]. Thus, in order to study the virulence of strains of T. gondii, the house mouse is the
preferred model.

Several studies have also shown that a correlation exists between disease

severity in humans and mouse virulence [33]. However, when studying virulence in mice, many
factors such as route of infection, life stage of the parasite, the number of passages of the parasite
in mice or cell culture, and the mouse host line used gives rise to variable results. This
inconsistency in the protocol makes the comparison of results between labs difficult. Thus, in
chapter 1, we discuss important factors to be considered when conducting T. gondii murine
virulence assays and propose a standardized methodology to facilitate the integration of T. gondii
virulence data throughout the research community. This will enable more efficient and effective
analysis of genetic and virulence patterns for this important parasite.
The most recent study performed to understand the diversity of T. gondii on a global scale
has shown that the population structure of T. gondii is more complex than thought originally.
This study showed that type II and III are the two dominant T. gondii lineages [36]. Despite the
dominance of different strains in different regions in the world, type II stands out as the most
dominant lineage globally. Furthermore, type II T. gondii was found to be most dominant in
Europe compared to other regions like Africa, North America or South America. Additionally,
congenital toxoplasmosis cases in Europe were caused by type II T. gondii [124]. Therefore, it is
critical to understand the origin and transmission pattern of the type II lineage to other regions of
the world. In order to study this, 299 type II samples were collected globally and analyzed to
study the diversity among these isolates. Furthermore, the current population structure suggests
that the second most dominant lineage, distributed globally, is the type III lineage of T. gondii
[36]. Based on the mouse virulence studies, almost all the strains belonging to the type III
lineage are avirulent and infections often result in the establishment of chronic infection in mice.
This could be one explanation for the global spread of type III T. gondii. However, despite its
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global spread, type III strains are more dominant in South America, and therefore, would be
interesting to investigate whether type III MRCA originated in South America, or if it is
transmitted and recently expanded in this region.
Toxoplasma gondii is a wide spread pathogen capable of infecting almost all warm-blooded
animals [1]. One-third of the human global population is infected with T. gondii. As T. gondii
can be transmitted to humans via consumption of contaminated meat, the study of the
seroprevalence rate among the wildlife is of importance [2]. Furthermore, the resistance of
wildlife to T. gondii favors the selection of more virulent strains [27, 28, 30]. Even though the
number of epidemiological studies is increasing, the reports for seroprevalence rate in wildlife
from certain regions have been limited. To, therefore, study the infection rate of T. gondii and the
genotypes circulating among wildlife from the southeastern region of United States, we collected
471 wildlife sera samples from six southeastern states namely, Tennessee, Kentucky, North
Carolina, South Carolina, Alabama, and Georgia.
Even though several of the pathways discussed above that are known to control the
bradyzoite differentiation/ maintenance have been studied, the master regulatory gene or
pathway for developmental switching is still unknown.

As described previously, studies have

predicted the possible genes/enzymes that contribute to bradyzoite differentiation under different
stress conditions such as NO, heat stress and nutrient starvation [95, 119, 122]. Although these
studies add to the pool of knowledge on type switching, they fail to establish a cohesive
representation

of

genes

necessary

for

bradyzoite

conversion

pathways.

Our

current

understanding of genes involved comes from studying the conversion of tachyzoites to
bradyzoite stage of the parasite which fails to paint the complete picture. In order to detect the
main regulatory gene(s) or pathway(s), it is undeniably important to study the interconversion
process between the two stages. A recent study using cDNA microarray analysis of tachyzoite to
bradyzoite conversion defective mutants (TBD), predicted the hierarchy of genes involved in
bradyzoite development [125]. This study supported the notion that multiple bradyzoites
inducing conditions and stresses should have a common pathway/genes leading to the stage
switching of Toxoplasma. In order to accurately characterize the most important genes, our
future study will focus on identifying the gene(s) that plays a major role in the conversion of
tachyzoites to bradyzoites and vice versa. The strategy involves the use of the physiologically
relevant NO donor drug, SNP as the stress model and the subsequent use of RNA sequencing at
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different time points throughout the interconversion process in vitro. This study focused on
establishing an experimental setup for converting tachyzoites into bradyzoites and vice versa
under external stress conditions. Further use of this experimental strategy could lead to the
identification of gene(s) that occupy the key position(s) in the bradyzoite development pathway.
This could be done by comparison of upregulated/downregulated genes over the time during
differentiation to bradyzoites. The reverse should be true when parasites revert to the tachyzoite
stage of the life cycle.
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CHAPTER 1: ON THE DETERMINATION OF TOXOPLASMA GONDII VIRULENCE
IN MICE
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1. Abstract
Toxoplasma gondii is one of the most successful pathogens on earth, capable of infecting an
extremely broad range of mammals and birds and causing potentially fatal disease in humans.
The house mouse (Mus musculus) has been used as the primary laboratory animal model for
determining the virulence of T. gondii strains. Epidemiological evidence also suggests a potential
association between virulence in mice and disease severity in human toxoplasmosis. However,
many factors can affect virulence measurements, including route of infection, life stage of the
parasite, number of passages of the parasite in mice or cell culture, and the mouse host line used.
Variability among these factors makes it difficult to compare results between different studies in
different laboratories. Here, we discuss important factors that should be considered when
carrying out T. gondii murine virulence assays and propose a standardized methodology that
should facilitate integration of T. gondii virulence data throughout the research community in
future studies and thereby enable more efficient and effective analysis of genetic and virulence
patterns for this important parasite.
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2. Introduction
Toxoplasma gondii is an obligate intracellular parasite capable of infecting almost all warmblooded animals, including humans [1].

Felids are the only known hosts, in which sexual

reproduction of the parasite occurs, resulting in the dissemination of oocysts into the
environment via defecation, and thus play a critical role in the transmission of T. gondii. It is
estimated that one third of the world’s human population is chronically infected with this parasite
[1]. Humans acquire infection by ingesting oocysts from contaminated food and water,
consuming undercooked meat containing tissue cysts, or by vertical transmission from mother to
fetus [1, 2]. The primary infection in immunocompetent individuals is mostly asymptomatic but
in some cases it can lead to ocular toxoplasmosis [3]. In immunocompromised individuals, such
as AIDS patients, reactivation of chronic infection can cause life threatening encephalitis [1, 4].
Susceptibility to T. gondii infection varies among different hosts: cattle, horses, rats, Old
World monkeys and humans are resistant to infection, while Australian marsupials and New
World monkeys are much more susceptible. The reasons for such differences are not clear, but
one reason may be a consequence of host-parasite co-evolution [1]. Laboratory mice are
generally sensitive to T. gondii infection and are often used as the preferred animal model to
determine the virulence of the parasite.
Virulence of T. gondii strains in mice varies with the genetic background of the parasites.
Some genotypes of T. gondii are lethal to all strains of mice regardless of the dose of parasites
administered, whereas other genotypes are non-lethal with a low dose of inoculation and can
readily establish chronic infection in mice [10, 11, 124, 126, 127].
Recent analysis of T. gondii genetic diversity has revealed geographical patterns of
genotype distribution [36]. Archetypal type II and type III strains are dominant in Europe and
North Africa, while types II, III, and 12 are dominant in North America, and Chinese type 1 is
most prevalent in East Asia. In contrast, T. gondii strains in South America are highly diverse
with no clear dominance of any particular genotypes. The genotypes prevalent in Europe, North
America, North Africa and Asia are non-lethal to mice at low infection dose, whereas a large
proportion of T. gondii strains identified in South America are highly virulent and lethal to mice
[126]. Population genetics and epidemiological studies have indicated a correlation between the
geographic variations of T. gondii genotype and disease manifestation in humans. For example,
severe symptoms associated with ocular toxoplasmosis are more frequently reported in Brazil
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than in European countries [3, 128], and numerous incidences of severe systemic toxoplasmosis
in immunocompetent adults from French Guiana have been reported, in some cases resulting in
the deaths of the afflicted individuals [27, 28, 129]. Taken together, virulence of different T.
gondii strains in mice appears to be generally correlated with disease manifestations in human
cases [33]. Therefore, determination of T. gondii virulence in mice could be invaluable in
predicting the potential outcome of human infections.
To obtain a better understanding of large-scale patterns of T. gondii virulence, it is essential
to have a standardized methodology for parasite virulence determination which allows for direct
comparison of the results obtained from different studies. Currently, a variety of mouse strains,
different life cycle stages of the parasite, and different routes of inoculation are used in T. gondii
virulence assays. This variation hinders meaningful comparisons and complicates integration of
data. In order to address this issue, in this review we summarize the common methodologies
used to determine T. gondii virulence in laboratory mice, and put forth a simple standardized
methodology that will facilitate more productive comparisons for future studies. Establishment
of a cohesive database for studying the relationship between T. gondii genotype and virulence in
mice should greatly enhance our understanding of parasite virulence patterns and aid in
predicting the outcome of T. gondii infection in humans.

3. Current methods for virulence assessment of T. gondii in mice
3.1 Virulence of tachyzoites, bradyzoites and oocysts of T. gondii
Toxoplasma gondii has a complex life cycle, and the specific stages of the parasite used for
inoculation may lead to marked differences in the outcomes of virulence in mice. The three
infectious forms of the parasite include: the rapidly dividing tachyzoite, responsible for systemic
invasion during primary infection; the slowly growing bradyzoite, associated with chronic
infection; and the sporozoite, sexually produced in mature oocysts. All three forms may be used t
o infect mice, but infection with different forms may have varied results in terms of virulence.
For example, mice inoculated orally with a single oocyst of the strain M-7741 were found to
exhibit 100% mortality after approximately two weeks, whereas 10 3 bradyzoite-containing tissue
cysts were required to produce this same mortality rate, and mice infected orally with 10 4
tachyzoites failed even to establish infection [130]. Higher pathogenicity of oocysts is also
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evident from a previous study in which mice infected orally with 10 oocysts died within two
weeks but mice orally infected with 10 tissue cysts failed to cause any infection [131]. Among
the three infectious stages of the parasite, oocysts in general are more virulent [130-132]. In
addition, oocysts are environmentally resistant, highly infectious, and thus hazardous to work
with, whereas tachyzoites and bradyzoites are readily killed even in water.

3.2 Change of T. gondii strain phenotypes after multiple passages in mice and cell culture
Changes in biological characteristics occur in T. gondii strains after passage in mice or cell
culture [127, 133-137].

Toxoplasma gondii strain M-7741, initially isolated from a sheep in

1950, was found to have lost the capacity to produce oocysts in cats after 30-35 continuous
passages in mice [134]. Similarly, after maintained in cell culture for 40 passages, the type I
strain GT1 lost the ability to produce oocysts in cats [135]. The most commonly used T. gondii
RH strain which was isolated from a six-year old child in 1939, has been found to no longer
produce oocysts in cats following prolonged maintenance through passage in laboratory mice or
cell culture, presumably due to unknown biological changes in parasites over time [137]. A
variety of phenotypic changes among several RH-derived clonal lineages were also observed
[127]. Differences among these lineages included larger plaque formation, enhanced survival
outside the cells, faster growth, and decreased differentiation. Enhanced virulence in mice for T.
gondii strains maintained in cell culture for several passages has been reported previously [138]
In that study, 28 out of 31 original isolates from Costa Rica established asymptomatic infection
in mice with only 3 isolates were highly virulent to mice. However, after five to ten passages, 7
of the 31 isolates were highly virulent and killed the mice [138]. Genetic variability among RH
lineages in different laboratories has been reported [139]; however, the cause-effect relationship
between genetic variations and phenotypes is unclear. Taken together, previous studies
highlighted the phenomenon of phenotypic changes during continuous passages in mice or cell
culture. Therefore any comparison of phenotypes among T. gondii isolates should be conducted
using the original or low passage stocks.

3.3 Routes of infection and virulence of T. gondii
The three common routes in determining T. gondii virulence in mice include intraperitoneal (IP)
injection, subcutaneous (SC) injection and per oral inoculation [130, 140].
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The IP injection

involves direct deposition of T. gondii parasites into the peritoneal cavity, whereas SC injection
deposits the parasites below the dermis. In oral infections, parasites are deposited into the
stomach of mice. Differences in infectivity and pathogenicity in mice have been observed
between IP and oral route of infections with T. gondii [130]. Mice infected orally with 10 tissue
cysts failed to establish infection, whereas the IP infection resulted in successful infection in
33% of mice. In the same study, results for the SC inoculation were comparable to the IP
injection [130].

Similar results were obtained in a separate study, wherein all mice orally

infected with 100 tissue cysts of a T. gondii isolate survived, while all mice infected with same
number of cysts by IP injection died an average of 12 days [131]. Another study showed that
C57BL/6 mice were highly sensitive to oral infection, but resistant to IP injection [140]. As
evident from these observations, the route of infection has an important effect on T. gondii
virulence in mice and thus a standardized inoculation method is necessary in order for direct
comparisons between different studies.

3.4 Variable susceptibility of different mouse lines to T. gondii infection
A high degree of variation in susceptibility to T. gondii has been observed among different lines
of laboratory mice [140-143]. The DBA/1, DBA/2, BALB/c, C57B1/6J, B10.D2, SW/SIM and
C3H/Bi mice showed markedly different outcomes when infected IP with tachyzoites of the C56
strain of T. gondii [141]. At a higher dosage (1x105 parasites), all DBA/2 and BALB/c mice died
within 12 days of inoculation, all B10.D2 mice died within 18 days, and the other mouse strains
showed mortality rates ranging from 60 to 90 percent at 30 days post infection. Outbred mice
(SW/SIM) were considerably resistant, with only 67% mortality at day 30 [141]. Mouse-line
dependent susceptibility was also observed in C57BL/6, LACA and BALB/c mice [140]. When
10 brain tissue cysts were used for IP inoculation, LACA mice were highly sensitive, whereas
C57BL/6 mice were resistant. However, by oral infection, the LACA mice were resistant and the
C57BL/6 mice were sensitive. BALB/c mice were resistant to both routes of infection [140]. A
more recent study observed that when oocysts were administered orally, the ME49 strain of T.
gondii was more pathogenic for transgenic (KO, HLA3.11, HLA2.1 and Hlab7), inbred
(C57/black and BALB/c) and outbred (SW) mouse lines in decreasing order [143]. It has been
demonstrated that BALB/c mice had a higher mortality rate than that of CBA/Ca mice during
acute infection; however, the inverse was true for chronic infection [142](. McLeod and others
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observed differences among the inbred mouse strains (C57BL/6 and A/J) infected per orally with
100 cysts of the ME49 strain [144]. C57BL/6 mice were found to be consistently susceptible,
whereas A/J mice were resistant to infection. Susceptible mouse lines had a weakened
gastrointestinal barrier, a lower splenic cytotoxic count, a weak IgM protective immune response
and

activation

of Kupffer

cells.

To

further

investigate

the

differences

between the

aforementioned mouse lines (A/J and C57BL/6), McLeod and others studied the survival rates
and brain cyst numbers of recombinant strains obtained by crossing the two lines, and found that
survival was controlled by H-2 complex and a set of at least five genetic loci [145]. The H-2a
haplotype was linked to resistance in a dominant manner, whereas the H-2b haplotype was found
to be recessively associated with susceptibility. Mice with the H-2a haplotype were found to
regulate the number of tissue cysts during chronic infection. Together, these studies demonstrate
the strong effect that genetic variability of laboratory mouse lines has on their susceptibility to T.
gondii infection. It illustrates the importance of selecting appropriate mouse lines with similar
resistance when making virulence comparisons.

3.5 Methods of preparing tachyzoites for infection
Most studies on T. gondii virulence in laboratory mice have employed the tachyzoites due to its
relative ease of preparation. The two most common ways of propagating tachyzoites include the
use of mice and cell culture [1]. For the former, T. gondii bradyzoites, tachyzoites or sporozoites
can be inoculated into the mice by IP injection. Within a week post infection, tachyzoites can be
harvested from the peritoneal exudates in the abdominal cavities of mice [146].

Toxoplasma

gondii strains that are highly virulent usually propagate well in mice and release a large amount
of free tachyzoites within 3-7 days post infection. However, T. gondii strains of low virulence
usually replicate slowly and free tachyzoites are difficult to obtain. To overcome this problem, it
is advisable to administer 10 µg/ml dexamethasone phosphate in drinking water, which will
suppress the murine immune response and facilitate tachyzoites production [1].
In laboratories with access to cell culture, T. gondii tachyzoites can be propagated and
maintained readily. Tachyzoites can proliferate in almost any mammalian cell lines, with
fibroblasts being the most commonly used [147]. Whether obtained from cell culture or mouse
peritoneal exudate, tachyzoites will often be mixed with a large amount of host cells. Therefore,
it is necessary to remove these cells and enrich tachyzoites. There are several methods to purify
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tachyzoites,

including

density

gradients,

sonication

and

trypsin

digestion,

differential

centrifugation, hemolysin digestion, filtration through glass wool, cellulose columns or sintered
glass, and polycarbonate filtration [146]. With the exception of sonication and trypsin digestion,
all of these methods are capable of removing greater than 90% of the mouse leukocytes without
altering parasite viability [146]. Recently, a comparison of tachyzoite purification by trypsin
digestion, filtration by 3-µm polycarbonate membrane, filtration by CF-11 cellulose, and
separation by percoll solution showed similar results [148]. Therefore, tachyzoites prepared by
trypsin digestion should be avoided for virulence testing in mice. In our laboratory, purification
by filtration through a 3-µm polycarbonate membrane is routinely conducted due to its ease of
use.

3.6 Dose-independent and dose-dependent mortality in mice
Earlier studies of mortality in mice have shown that some T. gondii strains such as those
belonging to the type I lineage are highly virulent to mice and kill all infected mice within two
weeks after infection regardless of inoculation dosage [10, 149]. For these acutely virulent T.
gondii strains, a single viable parasite is lethal to mice; therefore the mortality is doseindependent. In contrast, the majority of T. gondii strains can readily establish chronic infection
in mice if inoculated at low dosages, and mortality in mice is dose-dependent. The type II and III
T. gondii lineages belong to this group [10, 12, 149, 150]. Therefore, to accurately determine the
virulence of T. gondii strains, it is necessary to test a series of parasite concentrations ranging
from low to high inoculation doses. Any single dose inoculation will not be able to appropriately
assess the virulence of a particular T. gondii strain.

4. Proposed methodology for virulence assessment of T. gondii in mice
Virulence of T. gondii strains has been commonly defined by the mortality rate in laboratory
mice. However, due to the lack of a standard method, comparing results among published reports
is challenging. To make measurements of virulence of T. gondii in mice comparable across
different studies, it is imperative to establish a standardized method. Examination of the
cumulative mortality in mice infected via IP injection with serial dosages of tachyzoites is
arguably the most suitable method for accomplishing this goal. This method has been previously
used for the quantitative trait locus (QTL) analysis of T. gondii virulence determinants using
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genetic crosses that led to the discovery of the major parasite virulence factor ROP18 [13, 14,
151].
Here we propose a standard protocol to determine T. gondii virulence in mice (Figure 2.1):
(1). Propagate low-passage T. gondii strains in mice or cell culture. If propagating in mice,
administer 10 μg/ml dexamethasone in drinking water starting two days before inoculating
the parasites to suppress mouse immune response.
(2). Collect tachyzoites from a two-day passage of cell culture or from the peritoneal cavity
of infected mice within 3-7 days of infection. Purify tachyzoites by filtering through a 3-μm
polycarbonate filter.
(3). Collect the parasites in 15-ml centrifuge tube, centrifuge at 1000x g for 10 min at room
temperature. Discard supernatant and resuspend the parasites in 5 ml phosphate-buffered
saline (PBS).
(4). Determine the concentration of tachyzoites using a hemocytometer.
(5). Prepare ten-fold serial dilutions of 2x104 to 2x101 tachyzoites/ml using PBS.
(6). IP or SC inoculate 500 µl of parasites to 5 outbred mice (CD-1, CF-1 or Swiss-Webster)
for each dilution. Observe mice daily for four weeks. Euthanize severely ill mice.
(7). Record daily mortality. For those mice survived the infection for 4 weeks, collect blood
samples and determine seroconversion by modified agglutination test (MAT) test. The cutoff
value for positive infection is 1:25.
(8). Determine cumulative mortality in mice. To calculate cumulative mortality, three
sequential inoculation dosages should be analyzed; with the lowest dose resulting in only
partial infection of the mice (Table 2.1 and Table 2.2).
Below is the suggested protocol for the MAT test. It is slightly modified from previously
published protocol [1, 152].
(1). Materials and reagents needed are: 1x PBS pH 7.2; alkaline buffer [7.02 g NaCl, 3.09 g
boric acid, 24 ml of 1N NaOH, 4 g of bovine plasma albumin in 1 liter of distilled water,
adjust pH to 8.7, add 1 g sodium azide (0.1% final) as a preservative, final pH 8.2-8.4];
Toxoplasma whole cell antigen (RH strain prepared in cell culture, formalin-fixed, 2x108
tachyzoites/ml); 2-mercaptoethanol;

Evans blue dye (2 mg/ml in H2 O); 96-well U-bottom

microtiter plate; positive serum control (1:200 titer); and negative serum control.
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Low-passage T. gondii isolates

Expand in cell culture

Expand in mice

Filter to purify tachyzoites

Count parasite using hemocytometer

4

1

Prepare serial dilutions of tachyzoites (2x10 to 2x10 parasites/ml)

IP or SC injection to 5 outbred mice for each dose,
observe for 4 weeks
MAT test of the survivors

Determine accumulative mortality

Figure 2.1: Proposed methodology to test virulence of T. gondii strains in mice.
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Table 2.1: Calculation of cumulative mortality rate (Example 1).

Mice

Mice

Mice

No. mice

No. mice

survived

seronegative

seropositive

died

infected

1x104

1

0

1

4

5

1x103

3

0

3

2

5

1x102

4

2

2

1

3

1x101

5

5

0

0

0

Dosages

The number of mice injected per group is 5.
The dosages 1x104 , 1x103 , and 1x102 will be included for calculation. The cumulative mortality
is calculated based on the number of mice died divided by the number of mice infected. The
number of infected mice includes mice that have died and surviving mice that are MAT test
positive. The cumulative mortality for this example is (4+2+1) / (5+5+3) = 7/13 = 54%.
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Table 2.2: Calculation of cumulative mortality rate (Example 2).

Mice

Mice

Mice

No. mice

No. mice

survived

seronegative

seropositive

died

infected

1x104

0

0

0

5

5

1x103

0

0

0

5

5

1x102

2

1

1

3

4

1x101

4

3

1

1

2

Dosages

The number of mice injected per group is 5.
The dosages 1x103 , 1x102 , and 1x101 are included for calculation. The cumulative mortality is
(5+3+1) / (5+4+2) = 9/11 = 82%.
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(2). Mix 3.0 μl of serum sample with 72.0 μl PBS (1:25 dilution).
(3). Transfer 50 μl of diluted serum samples to the first row a U-bottom 96-well microtiter
plate (10 samples, plus one negative and one positive controls).
(4). Add 25 μl of PBS to the rest of wells using multichannel pipette.
(5). Make serial dilution to 1:3200 for each serum samples including the negative and
positive controls. Discard the last 25 μl of diluted serum samples.
(6). Prepare antigen mixture (for each 96-well plate) by mixing the following reagents: 2.5
ml alkaline buffer, 35 μl 2-mercaptoethanol, 50 μl Evans blue dye (2 mg/ml in H2 O), and 150
μl T. gondii MAT antigen.
(7). Mix antigen well by pipetting, immediately transfer 25 μl to each well using
multichannel pipette.
(8). Cover the plate with sealing tape and incubate at 37°C for 16 hours (overnight) Read
results. A pellet at the bottom of the well means negative. Samples without pellets are positive.

5. Future perspective
In recent years, two highly polymorphic rhoptry proteins (ROP18 and ROP5) have been
identified as the major virulence determinants in T. gondii [13-15, 22]. Together, the ROP18 and
ROP 5 play a role in the suppression of host innate immune response via formation of a complex
with murine immunity related GTPases, preventing destruction of the parasitophorous vacuole
[15, 21, 22]. Recently, using PCR-RFLP technique, it was shown that ROP18 and ROP5 allele
types are associated with the virulence of T. gondii in mice [126].

Therefore, we suggest

performing the above in vivo virulence test in mice and the genotyping test of ROP18 and ROP5
in parallel in the future. Over time, this will accumulate a large data set to further evaluate the
strength of the association between virulence in mice with the genotypes of ROP18 and ROP5
genes. If a strong association is confirmed, then genotyping of these genes can be used as a
simple test to predict T. gondii virulence in the future.
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CHAPTER 2: TO REVEAL THE MOST RECENT ANCESTOR AND TRANSMISSION
PATTERN OF TYPE II LINEAGE OF TOXOPLASMA GONDII
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1.Abstract
Toxoplasma gondii is one of the most successful pathogens on earth, capable of infecting all
mammals and birds. Recent population genetics studies in T. gondii revealed low diversity in
North America, Europe, Africa and Asia but high diversity in South America. Among the many
genotypes identified so far, the type II lineage is widespread and dominant in Europe. To
elucidate the most recent ancestor (MRCA) of type II and to study its transmission pattern, we
genotyped 296 type II isolates using 15 microsatellite markers. Our results showed that the type
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II strains from Europe have the highest diversity, followed by those from Africa, South America,
and North America. Type II isolates from North America are largely clustered together to the tip
of the phylogenetic tree. These results suggest that the MRCA of type II T. gondii may have
originated from Old World (Europe or Africa), and expanded and transmitted globally in the past
several hundred years.

2. Introduction
Toxoplasma gondii is the most successful zoonotic pathogen known today [1]. It has a complex
life cycle that propagates sexually in a definitive host (cats) and asexually in the intermediate
host (mammals and birds) [1]. Cats contaminate the environment by shedding T. gondii oocysts
in the feces. Both intermediate and definitive hosts can acquire the infection by oral ingestion of
oocysts from the environment, oral ingestion of tissue cysts in contaminated meat from infected
animals or by transplacental transmission via tachyzoites. One-third of people are chronically
infected worldwide [1, 153]. Infection in humans can cause ocular, congenital, or severe acute
disseminated toxoplasmosis. In immunocompromised patients, reactivation of latent infection
can cause life-threatening encephalitis [4].
Early genotyping studies on 106 isolates from Europe and North America using 6 PCRRFLP markers divided T. gondii isolates into three clonal types denoted as types I, II and III. The
three archetypical lineages of Toxoplasma showed variability in mouse virulence [10, 11].
Isolates belonging to type I were found to be highly virulent causing mortality during the acute
phase of infection even at very low doses [10, 12]. Type II and III strains cause chronic
infections at lower dosages. However, type II strains at moderate dosages can cause mortality in
mice [11]. The most recent data on diversity structure of Toxoplasma have been obtained from a
study carried on 1457 isolates using 10 PCR-RFLP markers. A total of 189 haplotypes were
found from 1457 isolates of T. gondii collected worldwide. Use of these markers revealed that
the type II strain is most dominant worldwide and comprises of 64.1% of the T. gondii
population in Europe compared to 45.4% and 43.9% in Egypt and North America respectively
[36]. Previously, type II has also been linked with congenital toxoplasmosis in Europe [124].
Even though type II is the most dominant clonal lineage of T. gondii worldwide, little is known
about its origin or transmission.
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Based on use of 10 PCR-RFLP markers all the strains included in this study are considered to
be type II with little genetic variability. However, use of markers designed for microsatellite
regions gives a higher discriminatory power to differentiate isolates belonging to the same
lineage. Microsatellite regions are found in eukaryotes with a mutation rate of 10-2 to 10-5, which
is 1000 times higher than the SNPs. The MS regions undergo length polymorphism as a result of
strand slippage process during DNA replication. The number of repeat units differs due to
addition or deletion, thus creating multiple alleles at an MS locus [154]. In this study, we utilized
15 previously designed microsatellite markers to obtain a better genetic differentiation among the
299 type II isolates available from around the world [155]. In this work, we attempted to
comprehend the diversity of type II T. gondii strains and track its transmission on a global scale.
The genetic variability among the type II isolates collected from different geographical regions
can shed some light on the origin and the transmission pattern of the type II clonal lineage of T.
gondii. We also discuss the factors such as agriculture and European expansion that may have
played a role in the transmission and expansion of type II in the last few hundred years.

3. Materials and Methods
DNA samples
DNA samples were collected from previous studies in our laboratory (Table 3.2 and Table 3.2)
[36]. Information about the location and host for these isolates were obtained from previously
published papers. DNA for all the isolates was either obtained from heart or brain tissues of
experimentally infected mice or tissue culture. Ethiopian feral cat isolates (n=14) included in our
study were collected from feral cats from Addis Ababa region in Ethiopia [156]. Egyptian feral
cat samples (n=26) were also isolated from Abourawash, Giza, Egypt [157]. Egypt dog samples
(n=8) were obtained from stray dogs supplied by a contractor from the region of Abourawash,
Giza, Egypt [158]. One Mali chicken sample was obtained from an infected chicken collected
from Mali [159]. Isolates from Norway fox (n=6) from the continent of Europe were obtained
from an arctic fox (Vulpes lagopus) population from the high arctic archipelago of Svalbard[160].
Samples from Austria (n=30), Portugal (n=4) and Israel (n=4) included in our study were
obtained from free range/backyard chickens [161]. T. gondii isolates from pigs (n=16) were all
derived from adult pigs (sows) from Iowa [162]. Samples collected from Maryland (n=19) were
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isolated from lambs from a slaughter house in Baltimore, Maryland [163]. Lambs were between 6
to 12 months old and were raised in Maryland, Virginia and West Virginia. One sample from
New Jersey was obtained from a white-tailed deer during the 2011-2012 hunting season. Samples
acquired from Brazil (n=2) were collected from sheep from two slaughter houses in Botucatu
region, Sao Paulo state [164]. T. gondii DNA samples obtained from Chile (n=16) were collected
from naturally infected chicken from rural farms spread around 85 different properties [165].
Four samples (PSC, 3440, FUN and CHA) included in this study were obtained from different
AIDS patients with acute toxoplasmic encephalitis [11]. Two samples (DEG and Tg132) were
obtained from non-AIDS- related human infections [11]. One sample was isolated from sheep
from the Huzhu city of Qinghai province of China [166]. The information of hosts and location
for previously unpublished samples are included in the study (Table 3.2 and Table 3.3).

Genotyping with MS markers
Genotyping of T. gondii isolates was performed using 15 MS markers located on 11 different
chromosomes in a single multiplex PCR reaction [155].

Primers were used at the working

concentration of 29.4 μM, except primers B18, N82, AA, and XI.I. Markers B18 and N82 had
more PCR products than other markers; therefore, the concentration was reduced to 17.64 μM.
Alternatively, markers AA and XI.1 had significantly less PCR product and so the concentration
in the multiplex mix was increased to 82.3 μM and 58.82 μM respectively. The microsatellite
sequences were amplified by multiplex PCR carried out in 25 μl reactions using the reagents
provided in a Qiagen multiplex PCR kit in 96 well plates. Non-type II reference strains included 5
isolates; GT1 (type I, ToxoDB PCR-RFLP genotype #10), CTG (type III, ToxoDB genotype #2),
MAS (ToxoDB genotype #17), TgCgCa1 (ToxoDB genotype #66) and TgCatBr5 (ToxoDB
genotype #19). A PCR reaction without DNA was used as a negative control to check for any
DNA contamination during the procedure. PCR products were diluted in deionized formamide
and the dilution factor was optimized based on the quantity of PCR product estimated from
running a 2.5% agarose gel. 1µl of each diluted PCR product was mixed with 0.5 µl of a dyelabeled internal size standard (ROX 500; Applied Bio-systems) and deionized formamide [155].
This mixture was later denatured and electrophoresed using an automatic sequencer (3730 DNA
analyzer; Applied Bio-systems). The size of the base pairs was determined using Peak-Scanner
analysis software (version 2.0; Applied Bio-systems).
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Data analysis
The multilocus microsatellite typing data was coded for all genetic loci. For a given locus, the
DNA banding pattern was coded with a string of 1s and 0s. Phylogenetic network and neighborjoining tree were generated by SplitsTree 4.8 [167]. A network tree was generated for 433
samples that included 296 type II and 139 non-type II samples collected from different regions of
the world (Table 3.2). Additionally, a rooted NJ tree for 301 samples (296 type II + 5 non type II
as outgroup) was constructed using Fig tree v1.4.2 (Andrew Rambaut, Institute of Evolutionary
Biology, University of Edinburgh, 2006) (Table 3.3). Basic statistics for quantitative gene
diversity within populations were calculated using Arlequin v 3.5 [168] (Table 3.4).

4. Results
In the phylogenetic network tree generated for 435 samples, type II samples (n=296) were found
to be clustered together. Non-type II samples (n=139) were found clustered with longer branch
lengths (Table 3.1 and Figure 3.1). A total of 296 type II T. gondii isolates were analyzed by
15 Microsatellite markers (Table 3.3). These samples were divided into five regional groups,
including

Africa (n=59), Europe (n=116), North America (n=99), South America (n=18), and

others (n=4).

The majority of these samples were reported in previous publications (Table 3.3

and Figure 3.2) [36]. Based on PCR-RFLP typing results, all 296 samples belong to the Toxo
DB genotype #1 or # 3 that together are considered to be type II. Five non-type II samples;
including GT1 (type I), CTG (type III), MAS, TgCrCa1 and TgCatBr5 (atypical) were included
as an outgroup for phylogenetic analysis.
In total, 205 unique microsatellite (MS) types were identified among the 296 type II
samples (Table 3.3). This includes 90 MS genotypes from 116 European isolates, 43 MS
genotypes from 59 African samples, 2 MS genotypes from 4 Asian isolates, 59 MS genotypes
from 99 North America isolates, and 11 MS genotypes from 18 South America isolates. Overall,
samples from the same geographical region appear to cluster together.
The branch length for the European type II isolates appeared to be much longer in
comparison to isolates from other regions (Figure 3.2). Four samples collected from Germany
(D15875, D15891, 3440 and PSC) were found to be quite different from other isolates from the
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Color

Type of T. gondii

Red

Type II (n=296)

Black

Non-type II (n=139)

Figure 3.1: Phylogenetic network tree constructed for 435 isolates of T. gondii using Splits
tree v 4.3.1.
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Figure 3.2: Rooted tree for 285 isolated of T. gondii analyzed with 15 microsatellite
markers constructed using Fig tree v1.4.2.
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Figure 3.2 (continued)
43

Color

Region

Purple

Europe (n=116)

Green

North America (n=99)

Orange

South America (n=18)

Red

Africa (n=59)

Blue

Others (n=4)

Black

Non-type II (n=5)

Figure 3.2 (continued)
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Table 3.1: Location and frequency of samples for 296 types II T. gondii isolates.

Region of T. gondii isolate

Number of Samples

Ethiopia

14

Egypt

35

Mali

1

South Africa

9

France

43

Austria

30

Portugal

13

Belgium

9

Norway

7

Israel

4

Romania

2

Germany

19

England

1

UK

1

Iowa

16

NewEngland

20

Maryland

19
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Table 3.1 (continued)
Region of T. gondii isolate

Number of Samples

Illinois

11

Cleaveland

19

USA

10

Minnesota

5

Wisconsin

4

Grenada

2

Colorado

1

Chile

16

Brazil

2

China

1

Japan

2

Australia

1
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European continent. These samples appeared to be separated from the European cluster and were
embedded into the cluster of North American isolates.
In Africa, a total of 59 samples had 43 unique genotypes. The branch lengths appeared to be
longer when compared to North American isolates. Samples from North Africa (Ethiopia and
Egypt) were found to be quite diverse and were distributed within the European isolates. On the
other hand, isolates from South Africa were found to be clustered together (Figure 3.2). Overall
the diversity of samples from Africa was comparable to European isolates.
In North America there appeared to be a high degree of genetic uniformity. Out of 99
samples obtained, 59 unique genotypes were identified. Despite the diverse sampling of isolates,
branch length appeared to be shorter and samples were clustered together forming an ingroup
within the old world isolates of Europe and Africa. A few isolates from Cleveland (G25/M291,
G22/M277, G191/M329, TX618G237M574, and TX618G658MNTKO) and Iowa (P35, P52 and
P54) were separated from the North American cluster and were emebedded within European
isolates (Figure 3.2).
Even though the available South American isolates were limited (n=18), the diversity was
reasonably high, with 11 unique genotypes identified. Samples from Chile and Brazil were also
found to be rooted within Old World isolates but did not belong to one cluster. Rather, isolates
were divided into several groups dispersed within the Old World samples (Figure 3.2).
The diversity within Type II T. gondii populations from different geographical areas was
quantified using Arlequin v 3.5 [168]. The results are summarized in (Table 3.4). The gene
diversity observed among the four populations from high to low was in the following order;
Europe > Africa > South America > North America.

5. Conclusions
The compiled microsatellite genotyping results for 296 isolates revealed high genetic diversity
for isolates from Europe and Africa in comparison to the New World isolates from North and
South America (Figure 3.2 and Table 3.3). In addition, all type II strains from North and South
America shared common relatives towards the Old World isolates. Thus, our findings indicate
that the most common recent ancestor (MCRA) of the type II T. gondii may have originated from
the Old World (Europe and Africa) and likely to have transmitted to the New World (North and
South America) from the Old World. Understanding the origin and transmission of the type II
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lineage is of interest as it is most dominant lineage spread globally, and knowledge gathered
from the study on this lineage may provide information regarding the spread of other zoonotic
diseases.
In the network tree generated for 433 isolates, type II samples clustered at one end of the
phylogenetic tree with smaller branch lengths, indicating that type II samples may have
experienced recent expansion (Figure 3.1). A large number of unique MS genotypes (n=90)
were found among type II samples (n=116) collected from diverse locations in Europe. Further,
the phylogenetic rooted tree for the type II samples showed deeper branch lengths for the
European isolates and situates European samples in an ancestral position (Table 3.3 and Figure
3.2). This suggests that type II isolates from Europe are older. Moreover, quantitative
comparison of genetic diversity among the four populations also revealed an overall higher
(0.3686 ±

0.1975) diversity for the European isolates (Table 3.4). Similar to the European

isolates, the branch length and average gene diversity per locus (0.3504± 0.1903) was found to
be high for African isolates. Together, these results suggest that the MRCA for type II T. gondii
may have originated in the Old World, comprised of Europe and Africa (average gene diversity
of 0.3775 ± 0.2012). In addition to the shorter branch lengths and lower gene diversity (0.2632 ±
0.1469), the majority of isolates from North and South America appeared to be embedded within
the Old World isolates suggesting that type II may have transmitted from the Old World
continents to the New World of America. Several major factors could have played a role in the
transmission of type II lineage. Agriculture began approximately 11,000 years ago in the fertile
crescent area near Europe and Africa [169]. Agriculture as an occupation conferred enormous
advantages to farmers, and this resulted in expansion and dispersal of the farming population
[170]. This is also reflected in a sudden rise in the human population during this period.
Agriculture leads to an increase in the availability of grain crops that attract house mice and cats,
which in turn increases their population density and proximity humans [171, 172]. Altogether,
the advent of agriculture could have served as a factor in the expansion of T. gondii in Europe
and Africa. Furthermore, European expansion (approximately within the last 500 years) may
have introduced type II to the new world via maritime trading of goods, transportation of pets
(including cats), slave trade routes, or accidental transport of infected rodents from Europe [173].
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Table 3.4: Basic statistics for type II T. gondii populations from different geographical
regions.

Europe

Number of isolates
Number

of

Africa

116

MS 90

North

South/Central

Old

New

America

America

World

World

59

99

18

175

117

43

59

11

133

70

0.2641
± 0.1544

0.3775
± 0.2012

0.2632
± 0.1469

genotypes
Average

0.3686 0.3504 0.2193
±0.1975 ±0.1903 ± 0.1259

Gene diversity

Due to small sample size of only four isolates; samples from Japan (2), China (1), and Australia
(1) were not included in analysis.

+

+

-+

North America

+

+

-

South America

+

+

+

+

+

+

-

+
South America

+

-

-

+

+
Europe

New World

Africa

Old World

+

North America

+
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+

New World

Europe

-

Old World

Africa

The genetically clonal population of type II isolates in North America could also be attributed to
the ‘Founder Effect’. A change in landscape owing to the encroachment of forest areas for the
purpose of farming leads to the replacement of wild animals by domestic animals [173]. This
combined with the agricultural revolution may have led to the expansion of a limited number of
successful strains from Europe, eventually reducing their diversity. In contrast to North
American isolates, which cluster together, isolates from South America appeared to be spread
within the Old World cluster and showed a higher gene diversity over loci. This suggests that
transmission of isolates to South America from the Old World may have occurred several times
independently. From the limited number of samples available from South America for this study,
the majority were derived from Chile. The west coast of Chile is encompassed by the Pacific
Ocean which serves as the major body of water used for the transportation of goods [36]. The
maritime transport and travel between the continents could have served as the medium for
multiple events of type II T. gondii transmission from Europe and could also explain the high
diversity of isolates seen in South America [174]. Another possible explanation could be the
dominance of wild animals in areas like the Amazon forest which serves as the hotspot for the
diversity of T. gondii [175]. The expansion of human populated areas could result in a spillover
of diverse type II strains from wildlife species leading to higher recombination rates and
genetically diverse populations. However, the limitation of our samples to human environments
fails to support the latter hypothesis. Better sampling from wildlife areas, as well as humandominated areas, is required in the future to draw a better conclusion for the higher diversity
observed in this region.

6. Future Perspectives
Our current study reveals that the MRCA for type II T. gondii exists in the Old World and that
type II is likely to have transmitted to the New World (America) from the Old World (Europe
and Africa). However, little is known regarding the origin of other clonal lineages (type I and
III). Thus, it will be interesting to further study the origin for other types of T. gondii and
determine whether the transmission pattern appears to follow the pattern of type II clonal
lineage. Based on our study, agriculture could be predicted as the main cause of transmission;
however, our understanding of the role of migratory birds and animals is limited. In some
regions like Brazil, pigeons can be infected with the parasite on a large scale and may thus play a
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critical role in the transmission in regions with large populations of the migratory birds. Other
species like sea otters and dolphins are also known to be infected and may play a role in the
transmission of T. gondii as well [219]. Therefore, in order to obtain a deeper understanding of
other factors, sampling from different hosts is necessary. This will also lead to a better
understanding of the transmission and evolution of other zoonotic pathogens. A recent study by
Mercier showed that human environments play a role in decreasing the diversity of T. gondii
isolates [175]. As the human population continues to rise, it will be fascinating to unearth and
predict the diversity structure of T. gondii in the coming future. The current global diversity
structure of T. gondii shows the dominance of certain types in different pockets of the world. It
will be of interest to unravel the factors behind this dominance in order to gain a better insight
about the important host or players in different regions of the world. In the future, this
knowledge will aid in controlling the spread of T .gondii in different regions of the world in the
event of an epidemic.
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CHAPTER 3: TO REVEAL GLOBAL TRANSMISSION OF TYPE III TOXOPLASMA
GONDII LINEAGE
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1.Abstract
Toxoplasma gondii is one of the major zoonotic pathogens infecting a third of the world
population. Previous studies have shown that population of T. gondii in northern hemisphere is
clonal, whereas many genotypes co-exist in the southern hemisphere. Despite the diversity in
South America, a large proportion of genotypes belong to type III lineage of T. gondii. Thus, to
unveil the origin and transmission pattern of type III lineage, genotyping for 15 microsatellite
markers was carried out for a total of 128 isolates. Furthermore, to study the expansion time,
Microsatellite (MS) data for type II and type III (n=437) was analyzed. Out study revealed that
type III lineage most recent common ancestor (MRCA) belongs to the New World and may have
disseminated from the New World (America) to the Old World (Europe and Africa).
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2. Introduction
The current population structure suggests that type III lineage of T. gondii is the second most
dominant lineage found globally [36]. Based on the mouse virulence studies, almost all the
strains belonging to type III lineage are avirulent and infections often result in establishing a
chronic infection in mice [10, 12]. Previous studies showed that type III lineage is wide spread
and frequently isolated in South America, which is in striking contrast to the most dominant type
II lineage. Thus, it would be interesting to investigate global transmission pattern of type III
lineage, and potential factors that facilitate its transmission.

3. Materials and Methods

DNA samples for MS analysis
DNA samples were collected from previous studies in our laboratory [36]. Location and host
information for these isolates were obtained from previously published papers (Table 4.1). DNA
for all the isolates was either obtained from the heart or brain tissues of experimentally infected
mice or cell culture. A total of 137 type III isolates were collected from 13 mammalian species;
including badger, bear, cat, chicken, dog, deer, dove, goat, goose, human, mongoose, sheep and
white-tailed deer. The isolates belong to five regions; including Africa(n=48), Europe(n=7),
North America(n=57), South America(n=16), Central America(n=9).

Genotyping using 15 MS markers
Genotyping of T. gondii isolates was performed using 15 MS markers located on 11 different
chromosomes in a single multiplex PCR reaction [155].

Primers were used at the working

concentration of 29.4 μM, except primers B18, N82, AA, and XI.I. Markers B18 and N82 had
more PCR product than other markers; therefore, the amount was reduced to 17.64 μM. On the
other hand markers AA and XI.1 had less PCR product and therefore their concentration in the
multiplex mix was increased to 82.3 μM and 58.82 μM respectively. The microsatellite sequences
were amplified by multiplex PCR carried out in 25 μl reactions using the reagents provided in a
Qiagen multiplex PCR kit in 96 well plates. Non-type III reference strains included 5 isolates;
GT1 (ToxoDB PCR-RFLP genotype #10, type I), PTG (ToxoDB genotype #1, type II), MAS
(ToxoDB genotype #17), TgCgCa1 (ToxoDB genotype #66) and TgCatBr5 (ToxoDB genotype
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#19). A PCR reaction without any DNA was used as a negative control to check for any DNA
contamination. PCR products were diluted in deionized formamide and the dilution factor was
optimized based on the quantification of the PCR products estimated from running a 2.5%
Agarose gel. 1 µl of each diluted PCR product was mixed with 0.5 µl of a dye-labeled internal
size standard (ROX 500; Applied Bio-systems) and deionized formamide. This mixture was later
denatured and electrophoresed using an automatic sequencer (3730 DNA analyzer; Applied Biosystems). The size of the base pairs was determined using Peak-Scanner analysis software
(version 2.0; Applied Bio-systems).

Data analysis
The multilocus microsatellite typing data for 123 type III isolates was coded for all genetic loci.
For a given locus, the DNA banding pattern was coded with a string of 1s and 0s. Phylogenetic
network and neighbor joining tree were generated by SplitsTree 4.8 [167]. A rooted NJ tree was
constructed for 142 samples (137 type III + 5 non-type III as outgroup) using Fig tree v1.4.2
(Andrew Rambaut, Institute of Evolutionary Biology, University of Edinburgh, 2006). A rooted
phylogenetic tree was generated using the non-type III reference strains as outgroup. Similarly, a
neighbor joining tree based on MS data was constructed for 437 (137 type III + 296 type II + 4
outgroups) isolates. Basic statistics for quantitative gene diversity within populations were
calculated using Arlequin v 3.5 [168].

4. Results
Based on the MS data, a rooted phylogenetic tree was constructed for type III isolates (n=123)
using 5 non-type III isolates as the outgroup (Figure 4.1). No geographical clustering of isolates
was observed for type III lineage isolates. Irrespective of the location or host, branch length
appeared to be more or less similar for all the isolates indicating similar divergence time. This
was also evident when the number of unique genotypes within each population were found to be
comparable. Furthermore, isolates from Central America were placed at the basal position, close
to the root.
To compare relative expansion time between type III and type II lineages, neighbor joining
network tree was constructed for 437 isolates; including 123 type III + 296 type II + 18
outgroups (Figure 4.2 and Table 4.2).
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Color

Region

Purple

Europe (n= 6)

Green

North America (n=30)

Orange

South America (n=6)

Red

Africa (n=48)

Blue

Others (n=31)

Black

Non-type II (n=5)

Figure 4.1: Phylogenetic rooted tree constructed for type III (n=123) T. gondii isolates.
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Figure 4.2: Phylogenetic neighbor joining tree (NJ) tree constructed for 437 T. gondii
isolates (123 type III + 296 type II + 18 outgroup).
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Type III

Type II

Color

Region

Purple

Europe

Green

North America

Orange

South America

Red

Africa

Blue

Others

Black

Non-type II (outgroup)

Figure 4.2 (continued)
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Table 4.3: Basic statistics for type III T. gondii populations from different geographical
regions.

Africa

North

Caribbean/Central

America

America

Number of isolates

48

30

31

Number

33

22

18

of

MS

genotypes
Average

0.2166
0.1645
±0.1259 ± 0.1016

Gene diversity

0.2698
± 0.1536

Due to small sample size; samples from Europe and South America were not included in
analysis.

+
+

+

+
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C.America/Carib
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C.America/Carib
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-

-

N. America

N. America

-

Africa

Africa

It was observed that type II and III isolates formed two distinct clusters, different from the
outgroups. Overall, type III lineage was less diverse than the type II lineages. However, the
overall branch lengths of type III strains was similar to that of type II strains in North America
type II isolates from North American were clustered together comparison to type III isolates.
Type III isolates from North America were distributed within the type III population and lacked
clustering (Figure 4.2).

5. Conclusions
We examined genetic diversity of the type III lineage by microsatellite analysis. Our results
suggest that the MRCA of type III lineage is likely originated in the New World and in recent
history, this lineage has been rapidly radiated to the Old World. Given that neighbor-joining tree
for 123 type III strains showed no association of genotypes with geographical locations, the type
III lineage may have spread from New World to the Old World many times independently in
recent history. This intense transmission could be explained by the fact that most type III strains
are avirulent to house mice. This may enable them to readily establish chronic infection in house
mice and be efficiently transmitted in the house mice – domestic cats life cycle. Furthermore,
Central America isolates placed near the root also suggests that the isolates from this region are
older and may speak for the origin of type III in this region (Figure 4.2).
NJ tree constructed for combined data for type II and III isolates showed some interesting
results for North American isolates. The obvious difference in topology between North American
isolates clusters suggests that unlike type II North American strains, type III isolates have been
transmitted to North America in multiple independent events. The most surprising information
based on our results was the fact that type III transmission from the New World to the Old World,
is opposite to that of type II lineage. The difference in the dissemination pattern for the two most
dominant lineages suggests that these lineages may have undergone different selective pressures
in the history of evolution. It is possible that dated back, type II may have migrated from the Old
World to the New World, however in recent times the modern day type III strains maybe able to
outcompete the type II strains and are being transmitted to the Old World. Our genetic analysis
showed that type III strains from America are placed closer to the root of the phylogenetic tree,
whereas samples from Africa and Europe are closer to the tip of the branches. A previous study
suggests the type III lineage was a recombinant from ancestral type II and type III lineages [220].
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Such recombination may provide the modern day type III lineage selective advantages. One
biological trait that could attribute to the widespread of type III strain is that they are non-virulent
to house mice, which may allow them to be easily transmistted by the domestic life cycle with
house mice (mus musculus) and cats (Felis). Therefore, it can be expected type III will further
expand and potentially become the most dominant lineage globally in the future.

6. Future Perspectives
Given that T. gondii can infect a variety of host species including mammals and birds, and
different hosts may contribute at different levels to the transmission of this parasite, predicting
the direction of evolution of T. gondii will be challenging. However, future studies focusing on
ecology of T. gondii infection, together with mathmatical modeling, will help us to better
understand the main animal species and environmental factors that influence spread of this
parasite, providing us necessary information to control or reduce transmission of T. gondii in
humans.
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CHAPTER 4: TOXOPLASMA GONDII SEROPREVALENCE AND GENOTYPE
DIVERSITY IN SELECT WILDLIFE SPECIES FROM THE SOUTHEASTERN
UNITED STATES
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1. Abstract
Background: Toxoplasma gondii is a wide spread protozoan parasite that infects humans and
other animals.

Previous studies indicate some genotypes of T. gondii are more frequently

isolated in wildlife than agricultural animals, suggesting a wild/feral animal diversity model. To
determine seroprevalence and genetic diversity of T. gondii in southeastern US wildlife, we
collected sera from 471 wild animals, including 453 mammals and 18 birds between 2011 and
2014. These serum samples were assayed for T. gondii infection using the modified agglutination
test (MAT). Heart or tongue tissues from 66 seropositive animals were bioassayed in mice and
19 isolates were obtained.

The isolated parasites were genotyped by the PCR-RFLP method

employing 10 genetic markers.
Results: One hundred and ninety-six of the 471 samples (41.6%) had a titer ≥ 1:32 and were
considered positive for T. gondii infection. Of the 453 mammals, 195 (43%) were seropositive,
whereas only one (5.6%) of the 18 birds was seropositive. Mammalian hosts with adequate
samples size (≥ 20) comprised white-tailed deer (n=241), feral hogs (n=100), raccoons (n=34),
and coyotes (n=22), with seroprevalence of 41.0%, 51.0%, 50.0%, and 72.7%, respectively.
Genotyping

revealed five distinct genotypes, including the ToxoDB PCR-RFLP genotype #5

(a.k.a type 12) for 15 isolates, genotype #3 (a.k.a. type II) for 1 isolate, genotypes #154, #167
and #216, each for 1 isolate. The results showed moderate to high infection rates of T. gondii in
white-tailed deer, feral hogs, raccoons, and coyotes. Genotyping results indicated limited genetic
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diversity with dominance of genotype #5, which has been reported as a major type in wildlife in
North America.
Conclusion: We conclude that T. gondii infection is common in game animals (white-tailed deer
and feral hogs) in the southeastern US, which may pose a food safety risk to human. Further
research is necessary to understand T. gondii transmission from wildlife to farm animals and
humans.

2. Introduction
Toxoplasmosis, caused by Toxoplasma gondii, is zoonotic and considered a leading cause of
human morbidity attributed to food borne illness in the United States [176]. One-third of the total
population in the world is infected by this pathogen [1]. Women infected with T. gondii during
pregnancy can have variable consequences including pregnancy complications, stillbirths, and
abortions. In immunocompromised patients, such as those with AIDS, encephalitis may occur,
which is often fatal [1]. Toxoplasmosis is one of five neglected parasitic infections, a group of
parasitic diseases that has been targeted by the Centers for Disease Control and Prevention
(CDC) for public health action. Infection with T. gondii can occur by ingestion of microscopic
oocysts in contaminated food or water, or by ingestion of tissue cysts in undercooked or raw
meat [2], making it an important foodborne zoonotic pathogen.
Toxoplasma gondii infection occurs in many species of wild mammals and birds, particularly
those that are carnivorous or ground dwelling. Clinical toxoplasmosis occurs in a wide variety of
US wildlife including threatened and endangered terrestrial mammals, avians, and marine
mammals [195, 196]. Epidemiology studies in white-tailed deer populations have reported high
seroprevalence rates (30-76%) in areas like Pennsylvania, Minnesota, Mississippi, New Jersey,
Iowa and Ohio [177-182]. A high seroprevalence (15-84%) was also observed in raccoons from
Iowa, New Jersey, Ohio, Kansas, Illinois, Florida, Pennsylvania, Virginia and Wisconsin [183185]. A high seroprevalence rate in red and gray foxes (85.9%) has also been reported in
Kentucky, Indiana, Michigan and Ohio [178, 186]. Wild hogs from California and black bears
from Pennsylvania also show high seroprevalence rates of 17% and 75-80% respectively [187].
Antibodies against T. gondii (7-17%) have also been found in wolves from remote areas in
Alaska [188, 189]. Genotyping of isolates from wildlife suggests that wild animals maintain a
much greater diversity of T. gondii genotypes than agricultural animals [190, 191]. There is no
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reported association between T. gondii genotypes and disease manifestation, but some evidence
suggests a relationship. For example, in South America where wild animal populations are more
dominant, severe cases of human toxoplasmosis were reported even in immunocompetent adults
[27, 28, 30, 192] and the majority of these infections were attributed to unique genotypes. Recent
studies have reported the presence of numerous genotypes in wildlife populations in North
America. Currently, ToxoDB PCR-RFLP genotypes #4 and #5, also known as type 12, are
recognized as the dominant type in North America wildlife [193, 194]. It is likely that some of
these T. gondii strains from wildlife are highly virulent, posing a potential wildlife health risk
and a higher risk for severe toxoplasmosis if transmitted in human populations.
The role of wildlife in the transmission of T. gondii demands increased efforts to catalog the
major sources of human T. gondii infection. Continued characterization is critical to
understanding the potential risks of T. gondii to wildlife populations and its zoonotic
implications. Seroprevalence and genotyping data from the southeast region have been
insufficient to determine the pattern of T. gondii transmission in the area. Hence, in this study,
we focused on determining seroprevalence and characterizing strains isolated from wildlife in the
southeastern United States.

3. Materials and Methods
Serum with or without corresponding fresh heart or tongue tissue samples was collected from
hunter-killed, road killed, nuisance killed (i.e. feral hogs), or research collected animals from
multiple southeastern states (Table 5.3). Tissue samples were refrigerated until serological
screening was completed.
Screening for T. gondii was performed at the clinical parasitology laboratory at the
University of Tennessee, College of Veterinary Medicine using the Modified Agglutination Test
(MAT) performed as previously described [152, 197] This assay is used to detect anti-T. gondii
antibodies in blood, serum, and other bodily fluids from a wide variety of wildlife and domestic
species. Animals were considered Toxoplasma positive if IgG antibodies were detected at > 1:32
dilution on MAT. Three to 5 grams of heart or tongue tissues from some seropositive hosts were
processed and used in bioassays of mice to propagate T. gondii [5]. Isolated T. gondii strains
were genotyped by multiplex multilocus nested PCR-RFLP (Mn-PCR-RFLP) employing 10
genetic markers [154].
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4. Results
Seroprevalence of T. gondii
A total of 471 serum/plasma samples were collected from 31 wildlife species (16 mammal and
15 bird species) from 2011 –2014 (Table 5.1). These samples originated in six southeast states
comprising Alabama, Georgia, Kentucky, North Carolina, South Carolina, and Tennessee (Table
5.1). From the 471 samples, 41.6% (196/471) had MAT titers ≥ 1:32 and were considered
positive for T. gondii infection (Table 5.2). Nine mammalian (white-tailed deer, opossum,
raccoon, coyote, feral hog, woodchuck, elk, gray fox, and mink) and 1 bird species (rock pigeon)
collected from five southeastern states had seropositive individuals (Table 5.1, Table 5.2). The
mammal hosts with samples size ≥ 10 individuals comprised white-tailed deer (n=241), feral
hogs (n=100), raccoons (n=34), coyotes (n=22), opossum (n=12), and gray squirrels (n=14) with
seroprevalence of 41%, 51%, 50%, 73%, 50%, and 0% respectively.
In Tennessee, 309 serum samples from 29 animal species were collected from 10
counties/sites and tested (Table 5.1). Overall, 37.5% (116/309) were positive for T. gondii
infection. A total of 167 white-tailed deer samples were collected from various counties
including Loudon, Fayette (Ames plantation), Anderson (Oakridge National Laboratories) and
Coffee (Arnold Engineering Development Complex) area; 39.5% (66/167) were positive. Thirtyfour raccoon samples were collected from Knox, Fayette, and Kingston counties, 50% (17/34)
were positive. Of the 27 feral hog serum samples collected from the Tennessee side of Great
Smoky Mountains National Park (GSMNP), 40.7% (11/27) were positive. From 17 coyote
samples collected in Fayette County, 11 (64.7%) were positive. Additionally, 50% (6/12) of
opossum from Knox and Fayette counties were positive. Overall, the results from Tennessee
indicate T. gondii infection is common in wildlife (Table 5.1).
In North Carolina, 74 serum samples (73 from feral hogs, 1 from a black bear) were collected
from the GSMNP (Table 5.1), 54.1% (40/74) were positive. For the feral hogs, 54.8% (40/73)
were positive to T. gondii infection. In South Carolina, 74 serum samples from white-tailed deer
in Laurens County were tested and 44.5% (33/74) were seropositive. In Georgia, 6 serum
samples were collected from 5 coyotes and 1 gray fox in Jefferson and Putnam counties (Table
5.1). The 5 samples from coyotes in Putnam County were all seropositive. The 1 sample from
the gray fox in Jefferson County tested seronegative. Four serum samples from 4 animal species
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Table 5.1: Seroprevalence rates of T. gondii categorized by State and County.

State of

County/Site

Origin
Loudon

Knox

Tennessee

Coffee

Ames Plant

GSMNP
GSMP
Kingston
Oak Ridge
AEDC,
Decherd
Jefferson
Roane
South
Carolina
North
Carolina
Georgia

Laurens
Cataloochee
GSMNP
Jefferson
Putnam
Brent

Species
white tailed
deer
Virginia
opossum
woodchuck
mink
raccoon
gray fox
opossum
pigeon
22 other
wildlife
species*
white tailed
deer
gray squirrel
coyote
white tailed
deer
raccoon
opossum
black bear
feral hog
feral hog
raccoon
white tailed
deer
white tailed
deer
raccoon
mink
white tailed
deer
feral hog
feral hog
black bear
gray fox
coyote
woodchuck

Seropositive/

Seroprevalence

Seroprevalence

total

(County)

(State)

5/9

55.6%

1/2
1/4
1/1
5/12
2/3
2/3
1/1

22.4% (13/58)

0/32
1/3

8.3% (1/12)

0/9
11/17
40/77
5/8
3/7
0/1
11/25
0/2
7/13

54.1% (59/109)

39.2% (11/28)
53.8%

18/64

28.1%

2/14

14.2%

0/1
0/1

0%
0%

33/74

44.5%

0/2
40/71
0/1
0/1
5/5
0/1

0%
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37.5% (116/309)

55.5%
0%
100%
0%

44.5%
54% (40/74)

83.3% (5/6)

Table 5.1 (continued)
State of
County/Site
Origin

Alabama

Kentucky

Hale

Perry
Knott

Species
eastern
cottontail
armadillo
gray
squirrel
elk
elk

Seropositive/
total

Seroprevalence
(County)

Seroprevalence
(State)

0%

0% (0/3)

66.6%
0%

50% (2/4)

0/1
0/1
0/1
2/3
0/1

Overall positive rate = 196/471 (41.6%)
GSMP= Great Smoky mountain Parkway, GSMNP=Great Smoky mountain National Park,
AEDC= Arnold Engineering development complex
*One samples from each of the following wildlife: American Crow, American robin, Beaver,
Belted Kingfisher, Chickadee, Chimney Swift, Chipmunk, Eastern Chipmunk, Fox squirrel, Gray
Catbird, Hermit Thrush, House Sparrow, Oven Bird, Pileated Woodpecker, Rock Pigeon, Tufted
Titmice, Turkey Vulture.
Two samples from: Blue Jay and Mourning Dove.
Three samples from: Cotton-tailed Rabbit
Four samples from: Eastern Cottontail and gray squirrel
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Table 5.2: Seroprevalence rate of T. gondii categorized by species.

1:2048 –
1:8192

>1:8192

Mammals
White tailed deer
Feral hog
Raccoon
Coyote
Opossum
Woodchuck
Elk
Gray fox
Mink
Virginia Opossum
Gray squirrel
Eastern cottontail
Cotton-tailed rabbit
Black bear
Armadillo
Beaver
Chipmunk
Eastern chipmunk
Fox squirrel
Birds
Pigeon
Blue jay
Mourning dove
American crow
American robin
Belted kingfisher
Chickadee
Chimney Swift
Gray Catbird
Hermit thrush
House sparrow
Oven bird
Pileated woodpecker

Sero-prevalence%

1:2561:1024

MAT titers

1:32 –
1:128

No. of
samples

241
100
34
22
10
5
4
4
2
2
14
5
3
2
1
1
1
1
1

142
49
17
6
5
4
2
2
1
1
14
5
3
2
1
1
1
1
1

59
33
6
5
2
1
1
2
0
1
0
0
0
0
0
0
0
0
0

11
13
7
4
2
0
1
0
0
0
0
0
0
0
0
0
0
0
0

11
4
0
4
1
0
0
0
1
0
0
0
0
0
0
0
0
0
0

18
1
4
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

41.0
51.0
50.0
72.7
50.0
20.0
50.0
50.0
50.0
50.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

1
2
2
1
1
1
1
1
1
1
1
1
1

0
2
2
1
1
1
1
1
1
1
1
1
1

1
0
0
0
0
0
0
0
0
0
0
0
0

0
0
0
0
0
0
0
0
0
0
0
0
0

0
0
0
0
0
0
0
0
0
0
0
0
0

0
0
0
0
0
0
0
0
0
0
0
0
0

100.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

<1:32

Host

69

1:2048 –
1:8192

>1:8192

Rock pigeon
Tufted Titmice
Turkey Vulture
Total

Seroprevalence%

1:2561:1024

MAT titers

1:32 –
1:128

No. of
samples

1
1
1

1
1
1

0
0
0

0
0
0

0
0
0

0
0
0

471

275

111

38

21

26

<1:32

Table 5.2 (continued)
Host
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0.0
0.0
0.0
41.6%
(196/471)

in Alabama were all negative (Table 5.1). Two of 4 samples from elk in Kentucky were positive
(50%).

Isolation and genotyping of T. gondii strains
The tissue samples (hearts and tongues) from 66 seropositive wildlife bioassayed in mice are
listed in Table 5.3. These samples comprised: 33 from white-tailed deer, 11 from feral hogs, 8
from raccoons, 8 from coyotes, 2 from elk, 2 from opossums, 1 from mink and 1 from gray fox.
Nineteen T. gondii isolates were obtained by bioassay (13 white-tailed deer, 3 feral hogs, 2
coyotes and 1 mink). All samples were genotyped by the 10 PCR-RFLP markers and the results
are summarized in Table 5.4. Five distinct genotypes were identified: ToxoDB PCR-RFLP
genotype #5 (15 isolates), #3 (1 isolate), #154 (1 isolate), #167 (1 isolate) and #216 (1 isolate).
Of the 13 isolates obtained from white-tailed deer, 9 were from South Carolina and 4 from
Tennessee.

5. Discussion
The present study demonstrates that T. gondii infection is widespread in wild mammals from the
southeastern United States. We collected sera from 471 wild animals, including 453 mammals
and 18 birds between 2011 and 2014. Overall, 41.6% were positive for T. gondii infection,
however, only one of the 18 birds was seropositive, whereas mammal hosts with samples size ≥
10 individuals all had high prevalence >40%. Type 12 (a. k. a. Toxo DB #5) is the most common
circulating genotype in wildlife in this region of the US, which is in agreement with previous
studies reporting the prevalence of type 12 genotype in white-tailed deer populations [36, 193].
Genotypes #156 and #167 have been previously reported from goats in the USA [199]. Two
isolates from coyote (TgWtdTn 122 and 142) and 1 mink isolate (TgMnkTn17) obtained from
Tennessee, belong to genotype #5 and #3 respectively. Genotype #3 belongs to type II clonal
lineage of T. gondii which is the most dominant lineage distributed globally. Furthermore, the 2
feral hog isolates (TgHogNc 194 and 227) from North Carolina also belonged to genotype #5,
which is commonly distributed in North America [193].
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Table 5.3: Results for bioassay in mice for T. gondii.

Sampl
e ID
13
14
16
17
37
40
43
60
77
78
79
80
88
95
98
99
102
110
113
119
121
122
124
126
133
136
138
142
151
152
173
174
176
194

Host
Elk
Elk
WTD
Mink
WTD
WTD
WTD
WTD
Gray fox
WTD
WTD
WTD
WTD
WTD
WTD
WTD
WTD
WTD
WTD
Raccoon
Raccoon
Coyote
Raccoon
Coyote
Raccoon
Opossum
Opossum
Coyote
Coyote
Coyote
Raccoon
Raccoon
Raccoon
FH

Loc
ation
KY
KY
TN
TN
SC
SC
SC
SC
TN
SC
SC
SC
SC
SC
SC
SC
SC
SC
SC
TN
TN
TN
TN
TN
TN
TN
TN
TN
GA
GA
TN
TN
TN
NC

Date
Sample
collected
10/8/2011
10/8/2011
9/19/2011
10/8/2011
10/15/2011
10/15/2011
10/15/2011
10/15/2011
10/17/2011
11/13/2011
11/13/2011
11/13/2011
11/13/2011
11/13/2011
11/13/2011
11/13/2011
11/13/2011
11/13/2011
11/13/2011
1/21/2012
1/21/2012
1/21/2012
1/21/2012
1/21/2012
1/27/2012
2/2/2012
2/2/2012
2/2/2012
3/28/2012
3/28/2012
6/13/2012
6/13/2012
6/13/2012
1/28/2013

MAT
titre
128
512
128
>8192
≥8192
≥8192
≥8192
≥8192
32
≥8192
2048
2048
≥8192
2048
2048
2048
≥8192
≥8192
≥8192
2048
2048
512
2048
≥8192
≥8192
512
512
4096
≥8192
4096
128
2048
2048
4096
72

Days
between
collection
and
inoculation
6
6
6
6
16
16
16
16
14
9
9
9
9
9
9
9
9
9
9
12
12
12
12
12
20
14
14
14
6
6
5
5
5
16

Mice
bioassaye
d
2
3
2
3
2
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
1
1
2
2
2
2
2
2
3
3
3
3
3
3

Isolate ID
Nd
Nd
Nd
TgMnkTn17
Nd
TgWtdSc40
TgWtdSc43
TgWtdSc60
Nd
TgWtdSc78
Nd
Nd
TgWtdSc88
Nd
TgWtdSc98
TgWtdSc99
Nd
TgWtdSc110
TgWtdSc113
Nd
Nd
TgCyTn122
Nd
Nd
Nd
Nd
Nd
TgCyTn142
Nd
Nd
Nd
Nd
Nd
TgHogNc194

Table 5.3 (continued)

Sampl
e ID

Host

195
FH
197
FH
201
FH
210
Raccoon
211
Coyote
212
Coyote
215
Coyote
227
FH
300
WTD
313
WTD
323
WTD
334
WTD
335
WTD
345
WTD
352
WTD
354
WTD
355
WTD
372
WTD
373
WTD
383
WTD
385
WTD
387
WTD
389
WTD
399
WTD
400
WTD
402
WTD
452
FH
458
FH
462
FH
466
FH
480
FH
WTD=white tailed

Loc
ation

Date
Sample
collected

NC
1/28/2013
NC
1/31/2013
NC
2/8/2013
TN
1/17/2013
TN
1/22/2013
TN
1/22/2013
TN
1/24/2013
NC
4/9/2013
TN
11/10/2013
TN
11/10/2013
TN
11/10/2013
TN
11/12/2013
TN
11/12/2013
TN
11/12/2013
TN
11/12/2013
TN
11/12/2013
TN
11/12/2013
TN
12/9/2013
TN
12/9/2013
TN
12/9/2013
TN
12/9/2013
TN
12/9/2013
TN
12/9/2013
TN
12/15/2013
TN
12/15/2013
TN
12/15/2013
NC
1/16/2014
NC
1/24/2014
NC
1/31/2014
NC
2/6/2014
NC
2/12/2014
deer, FH=feral hog.

MAT
titre

Days
between
collection
and
inoculation

Mice
bioassaye
d

Isolate ID

128
128
512
2048
2048
≥8192
2048
128
32
128
32
128
128
128
128
128
128
≥8192
512
512
512
≥8192
2048
2048
128
128
128
1024
128
128
128

16
16
20
42
37
35
35
16
10
10
10
8
9
8
8
8
8
4
4
4
4
4
4
8
8
8
18
10
20
14
8

2
2
2
2
3
2
2
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
3
3
3
3
3

Nd
Nd
Nd
Nd
Nd
Nd
Nd
TgHogNc227
Nd
Nd
Nd
Nd
TgWtdTn335
Nd
Nd
Nd
Nd
TgWtdTn372
Nd
Nd
Nd
TgWtdTn387
Nd
TgWtdTn399
Nd
Nd
TgHogNc452
Nd
Nd
Nd
Nd

SC=South Carolina, NC=North Carolina, TN=Tennessee, GA= Georgia, KY=Kentucky
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Table 5.4 Genotyping data for T. gondii isolates from wildlife.

ID

Host

Location

TgWtdSc40
TgWtdSc43
TgWtdSc60
TgWtdSc78
TgWtdSc99
TgWtdSc113
TgWtdSc88
TgWtdSc98

WTD
WTD
WTD
WTD
WTD
WTD
WTD
WTD

SC
SC
SC
SC
SC
SC
SC
SC

TgWtdSc110

WTD

SC

u-1
u-1
u-1
u-1
u-1
u-1
I
II or
III
I

TgHogNc194
TgHogNc227
TgHogNc452

FH
FH
FH

NC
NC
NC

TgMnkTn17

Mink

TgCyTn122
TgCyTn142
TgWtdTn335
TgWtdTn372
TgWtdTn387
TgWtdTn399

Coyote
Coyote
WTD
WTD
WTD
WTD

TN
TN
TN
TN
TN
TN
TN

SAG1

5’-3’
SAG2
II
II
II
II
II
II
II
I

alt.
SAG3
SAG2
II
II
II
II
II
II
II
II
II
II
II
II
II
III
I
I

BTUB

GRA6

II
II
II
II
II
II
II
I

II
II
II
II
II
II
II
I

c22 c29 L358 PK1 Apico
-8 -2
II
II
I
II
I
II
II
I
II
I
II
II
I
II
I
II
II
I
II
I
II
II
I
II
I
II
II
I
II
I
II u-1 III
II
I
I
III
III
III
III

Genotype
#5
#5
#5
#5
#5
#5
#154
#167

I

I

III

III

I

III

III

III

I

III

#216

u-1
u-1
u-1

II
II
II

II
II
II

II
II
II

II
II
II

II
II
II

II
II
II

nd
nd
II

I
I
I

nd
nd
II

nd
nd
I

#5
#5
#5

II or
III
u-1
u-1
u-1
u-1
u-1
u-1

II

II

II

II

II

II

II

II

II

I

#3

II
II
II
II
II
II

II
II
II
II
II
II

II
II
II
II
II
II

II
II
II
II
II
II

II
II
II
II
II
II

II
II
II
II
II
II

II
II
II
II
II
II

I
I
I
I
I
I

II
II
II
II
II
II

I
I
I
I
I
I

#5
#5
#5
#5
#5
#5

WTD=white tailed deer, FH=feral hog.
SC=South Carolina, NC=North Carolina, TN=Tennessee
nd = no data.
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6. Conclusion
In addition to the commonly observed genotypes, we also isolated several non-clonal types
circulating in sampled populations. This is of interest, as previous epidemiological studies have
reported a link between the prevalence of non-clonal genotypes and cases of congenital ocular
and severe disseminated toxoplasmosis in the area such Brazil [3]. White-tailed deer is one of the
most dominant wildlife species found in North America as well as venison is a common game
meat. Thus, the high seroprevalence in this species indicates that deer could serve as an
important source of human infection. Hence, people consuming wild venison should be advised
to cook the meat properly and use proper caution while handling the raw meat. Future
genotyping and seroprevalence studies in wildlife hosts and their role in the transmission cycle
will increase the understanding of risks associated with T. gondii in human populations.

7. Future perspectives
In this study, we measured the seroprevalence rate among wildlife from six southeastern United
States; including Tennessee, Georgia, North Carolina, South Carolina, Kentucky, and Alabama
and observed a high seroprevalence rate among the animals consumed by humans as game meat.
Even though the seroprevalence studies are rising, some areas remain underrepresented and may
prove as a risk to humans in the close vicinity. Thus, in future, more seroprevalence studies need
to be attempted, especially among wildlife, as consumption of game meat is a common practice.
Additionally, previous studies have shown that isolates circulating among wildlife may cause
severe cases of toxoplasmosis in humans. Thus, expansion of the existing knowledge regarding
strains of T. gondii infecting wildlife is of importance and should be a part of future goals.

75

CONCLUSIONS
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Toxoplasma is one of the pathogens included in the category of the neglected parasitic infections,
a group of parasitic diseases that has been targeted by the Centers for Disease Control and
Prevention (CDC) for public health action. This disease can be spread by contaminated food and
water sources as well as can be vertically transmitted. Furthermore, Toxoplasma has the capacity
to remain infectious in humans as well as almost all warm-blooded animals and can reactivate
under immunocompromised conditions causing a severe form of infection and in some cases
death. This asserts the importance of studying the transmission pattern, seroprevalence rates as
well as the genes that play a role in the maintenance of infection.
At present, the studies to understand the virulence of the parasite Toxoplasma have been
carried out using the mouse as the model organism. However, the methodology used between
labs varies considerably, making it difficult to compare results between different labs. Thus, it is
essential to establish a standard method in order to make results comparable and create a
database for future studies. Hence, in Chapter 1 we focused on discussing the different factors
that may lead to variability in results; including the route of infection, life stage of the parasite,
and the number of passages of the parasite in mice or cell culture, and the mouse host lines.
Further, we put forth a protocol to facilitate the integration of T. gondii virulence data throughout
the research community.
Recent studies using PCR-RFLP technique have established that the population and
diversity structure of Toxoplasma is complex. This study also showed that T. gondii is spread
globally, however; the dominance of certain lineages varies geographically. Type II even though
spread globally, was found to be most dominant in Europe compared to other regions; including
Africa, North and South America. Additionally, cases of congenital toxoplasmosis infected with
type II T. gondii were reported from the European continent. Thus, it is of interest to study the
transmission pattern and origin of this dominant lineage. Our study (Chapter 2) based on 299
type II isolates collected globally revealed that diversity of type II lineage is most in Europe and
Africa than any other continent. Furthermore, isolates from Europe and Africa were found to be
older based on the phylogenetic tree. Taken together, in this study we identified that the type II
lineage may have originated in the Old World comprise of Europe and Africa and have
transmitted to the New World of America from the Old World.
Similar to type II lineage, type III lineage was found out to be the second most common
lineages among all others. Unlike type II, type III is found in higher numbers in South America.
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It is therefore, interesting to investigate whether type III MRCA originated in South America, or
if it is transmitted and recently expanded in this region. Results of our study (Chapter 3) showed
that type III strains may have originated in the New World near Central America and are being
transmitted back to the Old World (Europe and Africa) from the New World (America).
Additionally, type III strains from North America were not clustered together when compared to
type II lineages from this region. This together suggests that type III lineage may have originated
in the New World and transmitted to North America independently during multiple events in the
history.
Toxoplasma gondii is capable of infecting almost all warm-blooded animals [1]. As T.
gondii can be transmitted to humans via consumption of contaminated meat, the study of the
seroprevalence rate among the wildlife is of importance [2]. Furthermore, severe cases of
toxoplasmosis have been reported to be infected with the strains found to be circulating among
wildlife areas [27, 28, 30]. Hunting is a common practice in the southern region of US, however;
the seroprevalence and genotyping reports of Toxoplasma are limited in this area. In Chapter 4
we focused on reporting the seroprevalence rate and genotyping of strains among the wildlife of
six regions of Tennessee, Georgia, North Carolina, South Carolina, Kentucky, and Georgia. Our
study on a collection of 471 wildlife sera samples showed high seroprevalence rate among game
meat animals including white-tailed deer. Furthermore, one previously unidentified genotype and
other atypical genotypes were found to be circulating among the wildlife belonging to these
regions.
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APPENDIX A: MODERN DAY T. GONDII GENETIC DIVERSITY IS DERIVED FROM
RECOMBINATION OF FIVE ANCESTRAL GENOMES

1. Introduction
T. gondii is one of the most widespread pathogens and is responsible for causing disease across
the globe [1]. The most recent knowledge on the diversity structure of T. gondii indicates that
population structure is much more complex than the previous notion of three clonal lineages
[11]. The accumulation of information from genotyping studies has also revealed previously
unknown genotypes of T. gondii. Previous study with 46 T. gondii samples has shown that the
mixing of four ancestral groups can define the population structure of T. gondii [221]. However,
this study was based on limited T. gondii strains, which may miss important ancestors. Thus, to
better understand the composition of current population structure and to correctly identify the
number of ancestral genomes, we utilized sequence data for 160 strains collected worldwide. Our
study is an update on the previous studies utilizing few strains representing the population of T.
gondii.

2. Materials and Methods
DNA sequencing
DNA sequencing was performed by our collaborators in China. A hundred and sixty DNA
samples were collected from previous studies in our laboratory [36]. Location and host
information for these isolates were obtained from previously published papers (Table A.1). DNA
for all the isolates was either obtained from the heart or brain tissues of experimentally infected
mice or cell culture. Fifty genetic loci across the 65 Mb T. gondii genome were pre-amplified by
multiplex PCR in three different groups.

SNP identification and STRUCTURE analysis
Sequence data available for 47 loci for a total of 160 strains of T. gondii was aligned and SNPs
was identified using Molecular Evolutionary Genetics Analysis (MEGA) software v 6.0. The
number of population clusters (k) were predicted individually for each marker as well as for
concatenated data for all SNPs, using STRUCTURE v2.3.4 ADMIXTURE and Linkage model
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respectively, with ancestral clusters set from K=1 to 10 (Table A.1). The results are averages
across three independent simulations with 10 3 burn-in iterations, followed by 103 MCMC
iterations.

Chromosome painting
Based on the population clusters identified for 37 loci using STRUCTURE v2.3.4, a chromosome
map was constructed using Microsoft Excel (2010).

Phylogenetic analysis
A neighbor joining tree was also constructed using sequence data of 43 loci for 160 (type I, II and
III) strains of T. gondii using SplitsTree 4.8 [167]

3. Results
To reveal the shared ancestry among isolates, local admixture analysis was conducted on SNPs
identified for 37 loci located on 14 different chromosomes for a total of 160 strains (Figure A.1).
Each strain was assigned a particular ancestral population based on admixture analysis and was
represented by a colored block. A chromosome painting map was constructed for the identified
population clusters for all 37 loci of 160 strains. The color block patterns were compared
horizontally among different populations to reveal the shared ancestry across 160 strains of T.
gondii (Figure A.1 ). When strains were aligned by clades identified using sequence data for 160
strains of T. gondii (Attachment 1), recombination was observed for the population as a whole.
Divison of haploblocks being shared across strains of specific lineages was not observed (Figure
A.1).
Although chromosome painting revealed the recombination events among the current
population, it failed to report the admixture pattern for the population as a whole. Thus, to
illustrate this more directly, STRUCTURE analysis was conducted for SNPs across all the 160
strains, using Linkage model (Figure A.2). This analysis revealed that the population is derived
from five ancestral genomes similar to strains; type I (BOF, GPHT, etc.), type II (PTG, DEG
etc.), type III (P89, TgCatBr3 etc.), MAS and TgCkGh1. Additionally, the modern day type I
appeared to be a result of inheritance of haploblock from the ancestral PTG (type II) and BOF or
GPHT (ancestral type I) strains (Figure A.2a). Whereas, the modern day type III strains was a
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result of a cross between ancestral PTG (type II) and P89 (ancestral type III) strains. These
findings were in agreement with a 2006 study [220]. Similar to the results from chromosome
painting, irrespective of the region, the population showed recombination (Figure A.2b). As
expected, the majority of isolates from North America (TgWtdUs8, TgSoUs1, TgShUs32 etc.)
showed genetic makeup similar to type II reference PTG strain (Figure A.2b). South America
population as a whole showed a lot of recombination and could be virtually divided into three
major clusters. A third of the population had the genetic makeup similar to GT1 (type I) strain,
one-third similar to MAS (atypical) and one-third similar to CTG (type III) (Figure A.2b).

4. Conclusions
The mosaic genomic patterns based on chromosome painting shows ongoing recombination in
the current population where large chromosomal haploblock are shared among members of
different clades (Figure A.1). Remarkably, our findings based on genome–wide polymorphic
data of 160 strains of T. gondii is in strong agreement with the previous reports [220, 221]. Our
data suggests that the current population (based on the assortment of 160 strains) is inherited
from five ancestral population clusters (Figure A.2a). Furthermore, based on our data the
proposed genealogy of three modern day reference strains representing the major clonal lineages
(GT1, PTG, and CTG) is in accordance with previous reports. The distribution of the colored
haploblock strongly suggests that a cross between type II (PTG/green) and type III (P89,
TgCatBr3 etc./blue) strain gave rise to modern day type III lineage represented by CTG (Figure
A.2a). The P89 population was previously referred as β strain in a 2006 study (Boyle et al.
2006). Similarly, modern day type I strain (GT1) is a result of a cross between type II
(PTG/green) and type I (BOF, GPHT, FOU etc. /red) strain, hypothetically referred as α strain in
a previous study [221]. Genome–wide SNPs STRUCTURE analysis for 160 strains, revealed that
the current population structure is a mixture of five ancestral groups. The number of ancestral
groups (five) suggested through our analysis is close to previously reported four ancestral
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Figure A.1: Chromosome painting of 160 T. gondii strains.
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Figure A.2: Analysis of present day T. gondii population structure using genome-wide
SNPs data for 160 strains using STRUCTURE.

FigureA.2a: Grouped by ancestor.
Figure A.2b: Grouped by geographical region.
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Figure A.2 (continued)
106

groups, however, this 2007 study was based on intron sequences of a limited number of T. gondii
strains (n=46) [220].
Based on the genome-wide SNPs analysis, South American strains also showed the dominance
of strains with haploblock similar to type I and atypical strains. This observation also reflects on
the severity of disease due to infection with T. gondii in South America. AIDS patients are often
found to be infected with type I strain and atypical strains are often associated with the severe
forms of diseases. Together, this study suggests that the current day population structure of T.
gondii is a result of recombination of five ancestral groups.

5. Future perspectives
Even though limited variability exists among different lineages of T. gondii, studies have
reported that certain genotypes are associated with severe forms of toxoplasmosis. Our study has
shown that strains from South America show similar haploblock pattern to type I like and
atypical strains, often associated with extreme cases of toxoplasmosis. Thus, in future, it will be
interesting to study the oral infectivity and transmissibility of representative strains from this
study. This will aid in exposing the admixture of lineages best adapted to domestic transmission.
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APPENDIX B: TO ESTABLISH AN EXPERIMENTAL PROTOCOL TO STUDY
PHASE INTERCONVERSION IN TOXOPLASMA GONDII

1. Introduction
The apicomplexan life cycle requires switching between distinct developmental stages. The life
cycle of T. gondii can be divided into three different stages: tachyzoite, bradyzoite and
sporozoite [1]. Tachyzoites represent the rapidly dividing stage whereas; bradyzoites are the
slow replicating form of the parasite responsible for chronic infection in the host. Following
infection, T. gondii enters into a rapidly dividing tachyzoite form that enters the lymph nodes and
can disseminate by infecting migratory cells like dendritic cells and macrophages. Eventually, on
encountering the host immune system stress responses, the tachyzoite form is converted to a
more slowly replicating dormant bradyzoite form. Bradyzoites enclosed in the cyst walls are
resistant to immune responses and can be retained primarily in brain and muscle neurons for the
entire lifespan of the infected host [1, 8]. Infections in immunocompetent individuals are mostly
asymptomatic. However, the key to T. gondii pathogenesis is its ability to differentiate from a
rapidly- replicating tachyzoites stage during acute infection to a relatively non-immunogenic,
dormant bradyzoite stage contained in tissue cysts [211]. Although tissue cysts are considered
dormant, they occasionally rupture and release bradyzoites that convert to faster-replicating
tachyzoites which in turn disseminate and can cause severe pathology and death in the absence
IFN-γ-dependent cell-mediated immune response [211-213]. Reactivation is thus a serious and
life-threatening condition in immune-compromised individuals. Bradyzoite formation is also of
concern during organ transplantation between individuals. The combination of drugs like
sulfonamide and pyrimethamine can readily inhibit tachyzoites; however, no drug currently
exists that inhibits the parasite in the bradyzoite form. Since tachyzoite to bradyzoite conversion
is the key to the establishment of a chronic infection and the reverse phenomenon is responsible
for life-threatening pathology, understanding of the molecular prerequisites for interconversion
will aid in developing a strategy to coerce the parasite out from latency and treat it using existing
drugs [93, 114, 116, 214]. In order to achieve this overarching aim, the goal of the study was to
establish a methodology to successfully convert the tachyzoite form into a bradyzoite form and
vice versa, in vitro using external stress factors.
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Specific Aims
2.1 To establish a protocol to study stress induced tachyzoite to bradyzoite conversion.
Previous studies have shown that tachyzoite to bradyzoite differentiation can be induced in vitro
in response to physiologically relevant exogenous stress like a NO donor (sodium nitroprusside).
Infected human foreskin fibroblast (HFF) cells will be cultured in medium containing sodium
nitroprusside (SNP) for three to four days at 37°C. Exposure of parasites to SNP will be used to
enhance bradyzoite differentiation in vitro [114, 116].

2.2 Time course expression analysis using RNA-seq.
Time course expression profiles will be carried out on the stress induced tachyzoites using RNAseq. RNA-seq technology should reveal a snapshot of RNA presence and quantity from a
genome at a given moment in time[215].

2.3 Analysis of the profile using GeneNet Package.
GeneNet package will be used to analyze time-series data obtained from RNA-seq to identify the
genes that are upregulated/downregulated [216, 217] (Figure B.1).

2.4 Gene knockout studies to confirm the role of the predicted gene.
Gene deletion assay will be performed for the predicted gene to confirm its role in regulating the
tachyzoite to bradyzoite conversion.
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Figure B.1: Examples of network structure of predicted genes analyzed using Gene
net analysis [216].
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2. Materials and Methods

Parasites
The ME49 strain originally isolated from the diaphragm of sheep was selected for this study. The
parasites were cultured in human foreskin fibroblast (HFF) cells grown in Dulbecco’s modified
Eagle medium containing 10% fetal bovine serum (FBS), 10 mM HEPES (pH 7.4), 1 mM
glutamine without antibiotics at 37°C under 5% CO 2.
In vitro differentiation of T. gondii
In

vitro

bradyzoite differentiation was achieved

using exogenous NO

donor (sodium

nitroprusside). A three-day confluent monolayer of HFF cells grown in 6-well plates was infected
with tachyzoites of ME49 strain.

Differentiation was induced by adding 70 μM SNP in

Dulbecco’s modified Eagle medium containing 10% fetal bovine serum (FBS), 10 mM HEPES
(pH 7.4), 1 mM glutamine without antibiotics. Cultures were incubated for 2 to 7 days with
medium changed daily. HFF cells infected with ME49 and cultured in medium without SNP were
used as a control for the study.

Immunostaining
HFF cells grown on chamber slides (Labtek, Campbell, CA) were infected with ME49 parasites
and monitored daily after infection. For immunostaining, cells were washed with PBS three
times and fixed using 4% formaldehyde for 30 minutes. Cells were permeabilized using 0.5%
Triton X-100 diluted in PBS for 20 min at RT and blocked in blocking buffer (0.1% Triton X100, 10% BSA diluted in PBS) for 1 hour at 37℃. Cells were incubated in primary antibody,
Rabbit anti-Bag1 antibody (1:100) overnight at 4℃.The cells were washed gently with PBS, and
the secondary antibody, Goat-anti-rabbit IgG-FITC (Sigma-Aldrich )(1:80 dilution) was added to
each well and incubated at 37℃ for 1 hour. The cells were washed gently with PBS 3 times.
Coverslips were removed from each well air-dried and mounted using VECTASHIELD antifading

mounting

medium

with

DAPI

(Vector

laboratories,

Immunofluorescence was observed under a confocal microscope.
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Burlingame,

CA).

Detection of Bag1 using Western blot
HFF cells cultured in 6 well plates were infected with ME49 and allowed to invade for 24 hours
or 4-6 parasites per vacuole stage. Medium (with or without SNP) was changed daily for both the
control and experimental sample. Respective 6 well plates were processed for the western blot.
Cells on these 6 well plates were harvested using a scraper and transferred to Eppendorf tubes.
Cells were lysed using a RIPA buffer containing 1% phosphatase inhibitor (Roche), and 1%
protease inhibitor (Roche). Protein concentrations were measured using the BCA method. 20 μg
of total protein for day 2 control, day 3 control, drug- treated day 2 –day 5 and revert day 1 and
2 was used for SDS-PAGE. Proteins in the gel were transferred to a LiCor Immobilon-FL PVDF
membrane and allowed to dry overnight. The next day the membranes were sliced into two parts
at 32 kDa and blocked in LiCor blocking buffer for 1 hour at 37°C. The upper part was incubated
with anti-β-tubulin (1:2500) (Dr.Sibley lab) and the bottom part was incubated with anti-Bag1
(1:2500) at 37°C for 1 hour. The membranes were washed with TBST 4x5 times. Membranes
were incubated with the secondary IR dye Goat anti-rabbit antibody at a 1:10000 dilution for 1
hour at room temperature followed by washing with TBST 4x5 and visualized using LiCor
Odyssey instrument.

3. Results
Previously studies have shown that exogenous stress can successfully induce differentiation of
tachyzoites in vitro. Sodium nitroprusside a NO donor has been reported as the most
physiologically relevant stress and therefore chosen as the stress factor for this study. Studies
have reported that ME49 strain of T. gondii is efficient in the formation of cysts in vitro. To
induce the conversion of tachyzoite to bradyzoite, 70 uM concentration of SNP was used for our
study. In order to confirm the interconversion process in vitro, Immunostaining and western
blotting were performed.

In vitro cyst development
Fluorescent intensity of bradyzoite stage specific protein Bag1 was used as a marker for the stage
conversion [218]. Cysts were stained with anti-Bag antibody and observed by confocal
microscopy. Representative examples of staining with Bag1 and DAPI for each day are shown in
the figure below (Figure B.2 a-d). The intensity of Bag1 increased from day 2 to day 4 post drug
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treatments. For the control, Bag1 intensity increases slightly in comparison to the drug treated
parasites and lysed at day 2 post infection. These results reveal that SNP drug treatment can
successfully retain the parasites as cysts in vitro. Additionally, on removing the stress, the
intensity of Bag1 fluorescence decreased till day 2 post stress removal and is lysed at Day 2
(Figure B.2 a-d). Together, these results show that the ME49 strain of T. gondii is converted to
cyst form in vitro using a NO donor and successfully reverts back to tachyzoite form on the
release of the exogenous stress.

Western Blot
To confirm the differentiation of tachyzoite to bradyzoite, Bag1 protein expression was
quantified using western blot (Figure B.3). Western blot analysis showed that Bag1 protein
expression increased from day 2 to day 5 for SNP treated plates. Whereas, the Bag1 protein was
absent for day 2 and day 3 control post infection. This confirms that in vitro, tachyzoites are
converted to bradyzoites post treatment with SNP. Interestingly, Bag1 protein expression appears
to be more at revert day 1 and 2 (SNP stress removed). This could be explained by the possibility
that Bag 1 protein is not immediately degraded on reversion to the tachyzoite form. However,
bradyzoites are confirmed to be reverted to tachyzoite form as the PV is lysed, following parasite
release on day 2 post stress removal.

4. Conclusion
So far we have successfully established a protocol to study the interconversion dynamics of T.
gondii. These results are in agreement with previous studies reporting the use of SNP as the
exogenous NO donor for conversion of tachyzoites to bradyzoites in vitro. Additionally, our
study also shows that on removing the external stress factor (in this study SNP), bradyzoites can
be converted back to tachyzoites form. However, this conversion seems to be really fast. Hence,
the time points used for the RNA profile in future should be decided accordingly.

5. Future perspectives
The above established protocol can be used to study the most important/ master regulatory
gene(s) involved in the conversion of tachyzoites into bradyzoite stage and vice versa for T.
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Figure B.2 (a-d): Expression of Bag1 (Green) antigen following the in vitro differentiation
of ME49 strain of T. gondii. On Day 2 and 3 in control plates, Bag1 is decreased in comparison
to day 2 and day 3 SNP treated plates. Day 2 Control and SNP were not treated with DAPI.
Hence, images shown are without DAPI. By day 4 and 5 Bag1 expression is increased. On
release of exogenous stress, Bag1 expression decreases. Nuclei are stained with DAPI (Blue). All
the pictures shown were recorded under similar optical conditions, imaged with the same
exposure time, and processed identically.
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Figure B.2a: Day 2 (Green: Bag1, No DAPI).

Figure B.2b: Day 3 (Green: Bag1 and Blue: DAPI).

Figure B.2 (continued)
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Figure B.2c: Day 3 SNP treated (Green: Bag1 and Blue: DAPI).

Figure B.2d: Revert day 1 and 2 SNP (Green: Bag1 and Blue: DAPI).

Figure B.2 (continued)

116

M.W

D2C

D3C

D2T

D3T

D4T

D5T

RD1

RD2

170

130
100
70

Β-tubulin

55
40
35

Βag1
25

M.W Molecular weight marker
D2C

Day 2 control flask

D3C

Day 3 Control flask

D2T

Day 2 SNP treated

D3T

Day 3 SNP treated

D4T

Day 4 SNP treated

D5T

Day 5 SNP treated

RD1

Revert day 1

RD2

Revert day 2

Figure B.3: Western blot analysis of in vitro Bag 1 protein expression of ME49 strain of T.
gondii. Bag 1 is not expressed for control day 2 and 3. Bag1 expression increases at day 2, day 3,
day 4 and day 5 for SNP treated plates.

117

T. gondii. To identify these genes, RNA will be isolated at day 0, 1, 2, 3 and 4 post infection as
well as 8 hours, 20 hours and 30 hours after the removal of SNP drug. These RNA samples will
then be processed for RNA seq and genes that appear to be down/upregulated during the switch
will be sorted by comparing the time points associated with tachyzoites to bradyzoite and
bradyzoite to tachyzoites interconversion. Genes identified using this method would then be
analyzed using gene networking software’s like GeneNet, which generates a network for the
selected genes in order to identify the master regulatory gene(s).

118

VITA
Pooja Saraf was born on January 13 th , 1988 in Nagpur, India. She attended Hislop College; RTM
Nagpur University, India where she received her Bachelors of Science degree with triple majors
in Botany, Chemistry and Biotechnology in 2008. She further received a Master’s degree in
Biotechnology from Hislop College; RTM Nagpur University, India in 2010. She started her
Ph.D. at the University of Tennessee Knoxville in August 2012 in the lab of Dr. Chunlei Su.
While her lab studies molecular parasitology and pathogenesis, work her research is focused on
studying the transmission pattern of major clonal lineages of Toxoplasma gondii. She has also
pursued research on establishing a protocol to identify the master regulatory genes for
interconversion of T. gondii. She completed her studies and graduated with a Doctor of
Philosophy in Microbiology in August 2017.

.

119

